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ABSTRACT
Modulation of Thiols and Pulmonary Immune Responses due to DEP Exposure
Nabil Al-Huamdi
Environmental exposure to diesel exhaust particles (DEP) has been of concern because of its
potential contribution to the increased prevalence of acute and chronic airway diseases. The
objective of this study was to investigate the role of thiol changes (due to DEP exposure) in
immune responses. Rats were exposed to OVA, DEP, or both by intratracheal instillation (IT)
and/or inhalation. IT-DEP exposure significantly increased the inflammatory parameters and
thiol levels in both Sprague Dawley and Brown Norway rats. Exposure to DEP and/or OVA
resulted in significant increases in neutrophils, LDH, total protein, and albumin content in lavage
fluid. Alveolar macrophage (AM) from DEP-exposed rats showed a time-dependent increase in
intracellular cysteine (CYSH) and glutathione (GSH). In lymph node cells (LNC), the
intracellular GSH increased significantly at 24 hours, and declined at 72 hours post exposure.
LNC-CYSH, and AM-CYSH and -GSH were increased at both 24 and 72 hours. DEP acutely
enhanced cystine uptake and reduction in both AM and LNC. In contrast, the intracellular level
of GSH in DEP-exposed LNC was significantly reduced despite the increased CYSH level and
GSH-Reductase ® activity when these cells were cultured with cystine. The DEP exposure
stimulated GSH-R activity and resulted in increased conversion of cystine to CYSH in both cell
types. Notable restoration of cystine uptake, reduction and GSH production was seen in AM of
DEP-exposed OVA-challenged rats. Threshold effect on both CYSH and GSH levels in BAL
and AM was seen after exposure to different concentrations of OVA alone. CB and DEP tended
to increase lung IFN-γ and IL-4 mRNA. The significant increases in serum OVA-specific IgG
and IgE and the increase in IL-4 mRNA in lung tissue were consistent with an adjuvant effect of
DEP or CB for OVA sensitization. In summary, DEP caused lung inflammation and thiol
changes (in both AM and LNC) and that these effects are particulate mediated.
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INTRODUCTION:
Because of the rapid growth in world population and the increasing worldwide migration
from rural to urban areas pollution is becoming an important political issue and public health
concern (Salvi et al., 1999). Exposure to motor vehicle generated air pollutants, like diesel
exhaust particles (DEP), has been associated with various health outcomes (mentioned in a large
number of epidemiological studies), like exacerbation of asthma, chronic bronchitis, respiratory
tract infections, ischaemic heart disease and stroke (Salvi and Holgate, 1999). Incomplete
combustion and formation of various gases, liquids and solid particles can result from the use of
diesel in motor vehicles. Submicron soot particles have been shown to mediate several adverse
effects. The concentration and size of the inhaled particles play an important role in the dose
deposited in the lung. Particles larger than 5 Fm reach the proximal airways and are eliminated
by mucociliary clearance, whereas particles with a diameter < 5 Fm reach the alveoli (Brain and
Valberg, 1979; Chow, 1995). An estimated 18,000 different high-molecular-weight organic
compounds are adsorbed to the carbonaceous core of DEP. Electron microscopic studies
demonstrated that over 80% of these particles have a size of # 0.1 Fm (Salvi and Holgate, 1999).
Recent focus has been on ultrafine particles (diameter < 0.05-0.10 Fm) because of their ability to
penetrate the epithelium and vascular walls and enter the bloodstream (Sydbom et al., 2001).
Increased carcinogenicity (Cammer et al., 1988), potentiation of autoimmune disorders (Yoshino
and Sagai, 1999), alterations in blood coagulability and increased cardiovascular disorders
(Schwartz et al., 1996; Seaton et al., 1995) are some of the biological health effects associated
with ultrafine DEP particles.
The crucial roles of glutathione (GSH) to cell survival and function have been well
studied. These roles include, serving as a cofactor for several enzymes; reduction of protein
disulfides and thus regulating sulfhydryl-dependent enzymes; required for the synthesis of DNA
precursors; and reduction of intracellular oxidants (free radicals, reactive metabolic
intermediates) thereby protecting cell from damage by these agents (Kosower and Kosower,
1969; Dolphin et al., 1989; and Taniguchi et al., 1989). Furthermore, thiols such as GSH and
CYSH have been reported to play an important role in the alteration of immune responses.
Lymphocytes exhibit strong membrane transport activity for CYSH, but only a weak transport
1

activity for cystine (Ishii et al., 1987). In contrast, AM have a strong capacity for cystine uptake
and the conversion of cystine into CYSH (Watanabe and Bannai, 1987). It has also been shown
that macrophages function as CYSH pumps that take up cystine and release CYSH upon
stimulation. This in turn results in an increase in the intracellular GSH level of activated
lymphocytes in the vicinity (Gmunder et al., 1990). These studies suggest that AM may regulate
T lymphocyte responses through thiol regulation. Thus any change in the thiol levels of AM,
may have an effect on T lymphocyte activity and in turn on immune responses. The objective of
this study was to investigate the role of thiol changes in the immune system after exposure to
DEP with and without ovalbumin (OVA) sensitization. In order to achieve our goal, three
experimental designs were included in which, rats were exposed to DEP, OVA, and combined
DEP and OVA.

LITERATURE REVIEW
DIESEL EXHAUST PARTICLES (DEP):
The prevalence and severity of asthma has increased worldwide in the last 20 years
(Eggleston et al., 1999; Koren and Utell, 1997). The reasons for this increase are not well
understood, but are likely to involve the complex interplay of genetic, social-economic,
behavioral, and environmental factors. Environmental factors include combined exposure to
airborne particulates (PM 10, PM 2.5) and a variety of allergens such as house dust mites and
pollens. The most prevalent form of asthma is allergic asthma. An allergic immune response to
an allergen, is characterized by the production of interleukin (IL)-4, IL-5, and IL-10 by the Th2
subset of CD4+ T lymphocytes (American thoracic society workshop, 1999). These cytokines
trigger IgE production by B cells and the recruitment of eosinophils (American thoracic society
workshop, 1999). Inflammation orchestrated by Th2 cytokines (IL-4, IL-5 and IL-13), and
thickening of all layers of the airway walls are common pathological observations in asthmatics
(Woolcock et al., 1997).
Diesel engine exhaust is an occupational and environmental health concern. Diesel
vehicles emit 2 to 20 times more nitrogen oxides and 30 to 100 times more particles than do
gasoline engine cars (Sagai et al., 1993). Diesel exhaust particles (DEP) are a complex mixture
2

of polycyclic aromatic hydrocarbons (PAH), ash, transition metals, and a carbon core. Major
PAH components of DEP include phenanthrenes 52%, fluorens 15%, naphthalenes 13%,
fluoranthrenes 10% and pyrenes 10% (Nel et al., 1998). The particulate phase of diesel engine
exhaust (DEP) is thought to contribute to the increased prevalence of acute and chronic airway
diseases. Exposure to DEP of more than 2 mg/m3 has been documented in underground mines,
railroad, construction, and in auto repair industries (Cass and Gray, 1995). Such exposures have
been associated with pulmonary inflammation, fibrosis, lung cancer, increased rate of respiratory
infections, and enhanced allergic sensitization (Iwai et al., 2000; Diaz-Sanchez et al., 1994; Yang
et al., 1997; Yang et al., 1999; Yang et al., 2001). Previously, work in this laboratory
demonstrated that both the organic and the particulate components play a major role in DEPinduced pulmonary toxicity. While the particulate is known to induce acute inflammatory
responses, the organic component has been shown to suppress AM secretion of proinflammatory
cytokines and cell-mediated immunity in response to bacterial infection (Yang et al., 1997; Yang
et al., 1999; Yang et al., 2001). In addition, DEP exposure has been linked to increased IgE
production (Diaz-Sanchez et al., 1994) and isotype switching in B cells to produce IgE in
humans (Fujieda et al., 1998) and in animals (Muranaka et al., 1986). These studies suggest that
DEP may suppress cellular, but enhance allergic immune responses.
Recently, a number of studies have shown that short-term exposure to diesel exhaust
particles (DEP) may exert a strong effect on the respiratory and immune system, suggesting that
DEP and perhaps, other particles as well, may be key environmental factors in augmenting
pulmonary allergic reactions. Indeed, the ability of DEP to enhance an immune response to
intranasally administered allergen and DEP has been demonstrated in both humans and rodents.
Diaz Sanchez et al., (1994 and 1995), showed that in vivo nasal challenge with 300 µg of DEP to
both healthy and allergic subjects enhances the amount of total IgE (but not of other
immunoglobulin isotypes) in human upper airways and increased the number of local IgEsecreting cells. This DEP exposure also increased both Th1- and Th2-type cytokines (including
IL-4, IL-6, IL-13, and interferon () in the nasal mucosa. In later studies, the same author (DiazSanchez et al. 1997) showed that combined exposure of ragweed allergen and DEP resulted in a
marked enhancement in the production of ragweed-specific IgE and mRNA for Th2-type
3

cytokines by cells in the nasal mucosa, when compared to challenge with ragweed allergen or
DEP alone of subjects with ragweed allergy.
The adjuvant effect of DEP on allergic sensitization has also been demonstrated in mice
using ovalbumin (OVA) as the allergen. Takano et al., (1997) showed that intranasally instilled
DEP aggravated OVA-induced airway inflammation, and markedly increased IL-5 levels and the
mRNA levels of IL-4, IL-2, and granulocyte macrophage-colony stimulating factor in lung
tissue. DEP exposure also exhibited adjuvant activity for anti-OVA specific IgG and IgE
production. In addition, the combined exposure of mice to DEP (3 or 6 mg/m3) by inhalation for
6 weeks and to intranasally administered OVA, resulted in higher anti-OVA IgE antibody titers
than mice exposed to DEP or OVA alone.
The cellular reactions to DEP and/or their particulate and organic components leading to
increased Th2 response are not yet clear. Studies in our laboratory have shown that DEP
suppresses pulmonary bacteria clearance and bacteria-induced macrophage production of TNF-α
(Yang et al. 1999; Yang et al., 2001). This effect was attributed to the organic component of
DEP. However, a number of studies have shown that various particles, including carbon black
(CB), which resembles the carbonaceous core of DEP, can enhance allergic sensitization
(Maejima et al., 1997; Lambert et al., 1999; Lambert et al., 2000). Carbon black, in particular,
has been demonstrated to enhance proliferation of antibody forming cells and both IgE and IgG
levels (Lovik et al., 1997; Van Zijverden et al., 2000). These studies suggested that DEP might
skew the immune response toward the Th2 side, whereas CB stimulates both Th1 and Th2
responses.
The inflammatory responses associated with particle stimulation involve oxidative stress
in the lung and possible alteration of thiol levels that are critical to the cytokine production and
cytotoxic activities of lymphocytes. Glutathione (GSH), for example, is known to affect NF-κB
activation and regulate lymphocyte immune responses (Droge et al., 1994; Haddad et al., 2000;
Takizawa et al., 1999). Studies by Shukla et al., (2000) have shown that inhalation of CB (300
µg/m3 air for 6 hr followed by 24 hr clean air exposure) causes an early increase in intracellular
oxidants and the mRNA levels of a number of NFκB-regulated genes, including TNF-α, IL-6,
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and interferon. These studies suggest that GSH may play a role in DEP and/or CB induced
immune responses.
DEP is thought to be mutagenic and/or carcinogenic as well as cytotoxic to bacteria and
mammalian cells (Kotin et al., 1995; Huisingh et al., 1978; Li AP 1981; Pederson TC 1981;
Schuetzle D 1983). It has been shown that the most mutagenic chemical fractions of DEP
extracted by organic solvents contain primarily oxygenated PAH derivatives including
compounds with hydroxy, ketone, quinone, acid anhydride, dihydroxy, and acid substituents on
parent PAH (Schuetzle et al., 1980; Pederson TC and Siak J-S 1981). It has also been suggested
that active oxygen species participate in the DEP toxicity (Sagai et al., 1993). The induction of 8hydroxydeoxyguanosine, which is produced by hydroxyl radicals (Kasai H and Nishimura S
1984) has been demonstrated in mice exposed to DEP (Nagashima et al., 1995). It has been also
reported that DEP components, probably quinoid or nitroaromatic structures, promote DNA
damage through redox cycling based generation of superoxide (Kumagai et al., 1997). Sagai et
al., (1993) reported that most of DEP induced acute lung toxicity is due to active oxygen
radicals, such as OA2- and AOH, and that DEP lethality is due to pulmonary edema associated with
endothelial cell damage. DEP-induced endothelial cell damage, during early exposure, is caused
by NO, superoxide, and related active oxygen species, including peroxynitrite (Bai et al., 2001).
It has been suggested by the Bai et al., (2001) that scavenging these active oxygen species would
be an efficient therapy for DEP-mediated cardiopulmonary diseases.
Fahy et al., (2000) reported that simultaneous exposure of allergic patients to DEP and
allergens could result in high local chemokine levels via MAP kinase pathway activation, which
could in turn increase the likelihood of reaching a critical threshold that would lead to the
initiation of respiratory allergic symptoms. DEP and their associated PAHs were shown to
enhance the recruitment of inflammatory cells and to trigger the release of numerous mediators
of inflammation, such as cytokines and adhesion molecules in both in vitro and in vivo studies
(Boland et al., 1999; Salvi et al., 1999). Exposure to low doses of diesel exhaust has been shown
to adversely affect the cytokine and antibody production in mice by altering CD4+ and CD8+ Tcell functions (Fujimaki et al., 2001).
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OVALBUMIN (OVA):
In the last decades allergic disorders in affluent countries has steadily increased (Peat,
1994). In food processing industry (e.g. egg proteins), workers could be occupationally exposed
and sensitized. Workers at egg processing plants could be exposed for 8 h or more daily to as
high as 360 µm/m3 of ovalbumin (NIOSH, 1988). The association between the increased levels
of immunoglobulins (IgE and IgG) and the exposure to ovalbumin in different animal models has
been reported (Andersson, 1980; Sedgwick and Holt, 1983; McMenamin et al., 1992; Renz et al.,
1992; Siegel et al., 1997; Siegel et al., 2000). Further more, ovalbumin has been used to
investigate the facilitation of the development of respiratory and intestinal allergies by the
occupational and environmental factors (Siegel et al., 2000; Watzl et al., 1999; Al-Humadi et al.,
2002-2). The low toxicity and documented antigenicity of this protein make it a popular choice
as an antigen of allergy and asthma modeling studies.

GLUTATHIONE AND CYSTEINE (GSH AND CYSH):
Glutathione is a tripeptide (γ-L-glutamyl-L-cysteinylglycine) which plays an important roles
in physiological homeostasis. One of these roles may be to help regulate lymphocyte functions.
Depletion of intracellular GSH by buthionine sulfoximine (BSO) caused a decrease in CD8+
cells and, inhibited, both the generation of large blast-like CD8+ cells and cytotoxic T
lymphocyte (CTL) activity (Gmunder and Droge, 1991). Several other important reported
biological functions for the glutathione include functioning as a coenzyme (Knox, 1960),
activation of thiol requiring enzymes (Fanger et al., 1970) and protection of cells against
oxidative damage (Fanger et al., 1970, Reed, 1969).
Glutathione, which has long been known for its protective function against oxidative cell
damage (Fanger et al., 1970), is thought to play a regulatory role in various lymphocyte
functions. Gmunder et al., (1990) reported that exogenously added CYSH increases the
intracellular GSH level and DNA synthesis in mitogen-stimulated lymphocytes, suggesting that
CYSH may also play a regulatory role in mediating immunologically relevant functions of
lymphocytes. The same author (Gmunder et al., 1991) showed that GSH mediated cytokine6

dependent DNA synthesis in T lymphocytes and depletion of intracellular GSH inhibited the
relevant DNA synthesis resulting in altered T lymphocyte activity.
Cysteine also has a regulatory role in the immune system and constitutes the majority of the
acid-soluble thiol content in cells. Exogenously added cysteine, or (syngeneic) macrophages
increases intracellular glutathione level and DNA synthesis activity in mitogenically stimulated
lymphocytes (Gmunder et al., 1990). Lymphocytes have strong membrane transport activity for
cysteine, but only a weak transport activity for cystine (Ishii et al., 1987). In contrast to
lymphocytes, macrophages have a strong membrane transport activity for cystine and also
release thiol compounds into the extracellular space (Watanabe and Bannai, 1987). It has also
been reported by Gmunder H et al., (1990) that: 1- Macrophages when stimulated generate
substantial amounts of cysteine and consume approximately equivalent amounts of cystine, 2Macrophages, when stimulated, function as a cysteine pump that take up cystine and releases
reduced cysteine, and 3- Macrophages causes an increase in the intracellular glutathione level of
activated lymphocytes in their vicinity.
Reactive oxygen species (ROS) plays an important role in immune responses (Watzl et
al., 1999; Oliveira et al., 1995; Wolfreys and Oliveira, 1997). The imbalance between
antioxidants, such as glutathione, and ROS levels may lead to oxidative stress. Thus, any
decrease in the GSH level could account at least in part for an increase in ROS levels. Indirectly,
this may affect immune responses. It has been suggested that GSH itself may play a critical role
in immune functions. Macrophages, dendritic cells, and B cells (as antigen presenting cells) are
central to the development of either Th1 or Th2 immunity, because antigen presentation and
recognition are required to initiate responses (Peterson et al., 1998). Also, Peterson et al, (1998)
reported that a selective inhibition of the cytokine production in response to Th1-associated, but
not Th2-associated antigens, was due to GSH depletion in APC. Other studies showed that APC
ability to reduce antigen disulfide bonds required before antigen processing was impaired when
GSH was severely depleted (Short et al., 1996). Also, this severe depletion decreased the activity
of thiol proteases crucial to antigen processing and cleavage of invariant chains in the major
7

histocompatibility complex class II (Mizuochi et al., 1994). However, many factors, other than
the extracellualr supply of thiols, have been recognized as modulators of the direction and the
magnitude of T-dependent responses such as; dose and route of antigen administration, type of
APC, presence of particular hormones, co-stimulatory molecule expression, and peptide affinity
for MHC determinants (Droge et al., 1994; O’Garra and Muphy, 1996; Constant and Bottomly,
1997). Lawrence et al., (2000) suggested that impairment of APC functions may be caused by
the reduction of GSH levels including antigen processing and presentation and that the thiols are
necessary for complete T cell activation.
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SPECIFIC OBJECTIVES:
The objectives of this study are to:
1- Develop a sensitive method for the quantification of specific thiols from biological samples
including BAL, alveolar macrophages, thymic, tracheal, and axiliary lymph nodes in rats.
2- Study the dose-response relationship between inhaled OVA and CYSH and GSH in BAL, AM
and LNC, and on immunoglobulin production.
3- Compare the pulmonary cellular response to intratracheal instillation vs inhalation of DEP.
4- Study the effects of DEP exposure on thiol levels, inflammatory response, and alveolar
macrophage functions in a Brown Norway rat model.
5- Study the effects of DEP exposure on cellular uptake and utilization of cystine, glutathione
reductase (GSH-R) activity, and the production of CYSH and GSH in AM and LNC.
6- Study the adjuvant activities of DEP and CB on OVA sensitization in Brown Norway rats, and
the potential role of GSH in OVA- and/or particle-mediated Th2 lymphocyte responses.
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SPECIFIC HYPOTHESES:
1- OVA affects thiol regulation in AM and LNC resulting in a perturbation of immunoglobuline
(Th2 induced allergic response) levels.
2- DEP exposure alters thiol levels in lymph node cells and bronchoalveolar lavage cells.
3- The adjuvant effect of DEP on IgE and pulmonary allergic responses is, at least in part,
mediated through its effects on thiol levels.
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MATERIALS AND METHODS
ANIMALS:
Male Sprague-Dawley (200-250 gm, Hilltop, Scottsdale, PA) rats were used. Brown
Norway (BN) were obtained from area K93 (200-250 gm), Charles River laboratories
(Stoneridge, NY) and were free of all respiratory viruses. Rats were maintained at 23 + 1 oC with
50 % relative humidity and a 12-hr light/dark cycle, and acclimated for 2 weeks before use.
Food and water were given ad libitum. All procedures were performed in accordance with the
American Association for Accreditation of Laboratory Animal Care (AAALAC) standards and
under approved National Institute of Occupational Safety and Health (NIOSH) and West
Virginia University (WVU) ACUC protocol.

PARTICULATE SAMPLE PREPARATIONS:
CB particles (Fisher Scientific, Fair Lawn, NJ) were autoclaved at 120 °C for 4 hours
before use. DEP (Standard reference material 1650, representing heavy duty engine with a mass
median aerodynamic diameter of 0.5 µm) were purchased from the National Institute of
Standards and Technology (Gaithersburg, MD). Endotoxin free sterile saline (Baxter Healthcare
Corporation, Deerfield, IL) was used to suspend the particles. The suspensions of CB and DEP
were sonicated for 1 min using an ultrasonic processor with a micro tip (Heat SystemUltrasonics, Plainview, NY) prior to intratracheal instillation.

ANIMAL EXPOSURES:
In order to achieve the outlined objectives, the following experimental design were used:
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OVA Exposure:
Five different concentrations of OVA (Sigma Chemical, St. Louis, MO) in endotoxin free
saline were aerosolized using a DeVilbiss-646 (DeVilbiss, Somerset, PA) nebulizer. A constant
feed of the OVA solution to the nebulizer was achieved using a syringe pump (Model # 901,
Harvard Apparatus, Dover, MA) at a flow rate of 1.22ml/min. To achieve the desired
concentrations of 7.2 , 68, 93, 111, and 156 mg/m3, filtered air was passed through the nebulizer,
and used as a diluent for the aerosolized OVA. The chamber OVA aerosol concentration was
determined by collecting samples onto 0.45 µm (Polycarbonate Membrane, Poretics Corporation,
Livermore, CA) filters from a chamber side port at a rate of 1 liter/minute. Filters were washed
with 10 ml of endotoxin free saline and analyzed for protein using the Coomassie blue dye
reagent (Bio-Rad Laboratories, Hercules, CA) against OVA standards. Rats were exposed to
OVA for 30 min on days 0, 7, 14 and 28. Control animals were exposed to aerosolized
endotoxin free saline.

DEP Exposure by Intratracheal Instillation or Inhalation:
Brown Norway rats weighing (200-250 gm) were dosed by either intratracheal instillation
(IT) with 5mg/kg (saline suspension) of DEP or exposed acutely using a nose-only chamber for 4
hours to 17mg/m3 DEP aerosol (Figure 12). Tissue was collected at 4, 24, and 72 hours following
IT and at 72 hours following aerosol exposure. Control rats were instilled with saline or given a
clean air sham exposure for the respective exposure routes.

IT-DEP Exposure and ex vivo16hr incubation of LNC or AM with or with out Cystine:
Male Sprague-Dawley (200-250 gm, Hilltop, Scottsdale, PA) rats were used. Brown
Norway (BN) (200-250 gm, Charles River, Stoneridge, NY) rats were used for strain comparison
purposes. Methohexital sodium (35 mg/kg body weight, ip; Eli Lilly Co., Indianapolis, IN) was
used to lightly anesthetize the animals prior to their placement in a vertical position for
intratracheal instillation (IT). A curved ball-tipped cannula (18 gauge) was used to briskly inject
the DEP-particulate suspension (5 mg/kg body weight) into the trachea. Control animals received
12

sterile saline vehicle. The instillation volume was 2 ml/kg body weight. AM and LNC were
collected at 4, 24, and 72 hours after exposure and used for CYSH and GSH determination. In
separate experiments, cell samples were collected at 72 hours post exposure for either GSH-R
activity measurements or cultured in Hepes (for 16 h) with or without cystine (24 µg/ml) for
CYSH and GSH assessment.

Combined IT-DEP or CB and OVA Exposure:
Male Brown Norway rats (Charles River, Stoneridge, NY), weighing 200-250 g, were
used. IT and inhalation procedures were performed as described above. Rats were exposed to
OVA for 30 min at day 1 after IT-exposure (on day 0) to DEP, CB, or saline, and then once a
week for 30 min on days 8, 15 and 29 (Table 5). The OVA chamber concentration was 90mg/m3
± 18. Control animals were exposed to aerosolized endotoxin free saline. All rats were sacrificed
at day 30. Rats were sacrificed 24 h after the last OVA challenge exposure to maximize potential
for identifying alteration in pulmonary inflammatory responses.

TISSUE PREPARATION:
Bronchoalveolar Lavage (BAL) and Biochemical Assays:
Rats were anesthetized with sodium pentobarbital (50 mg/kg, ip; Butler, Columbus, OH)
and euthanized by exsanguination of the abdominal aorta one day after the last inhalation
exposure. The trachea was cannulated and the lungs were lavaged with Ca2+/Mg2+-free
phosphate-buffered saline (PBS, 45 mM NaCl, 5 mM KCl, 1.9 mM NaH2PO4, 9.35 mM
Na2HPO4, and 5.5 mM glucose; pH 7.4), at a volume of 6 ml for the first lavage and 8 ml for the
subsequent lavages. The total lavage volume was 80 ml. The BAL fluid was centrifuged at 500
g for 10 min at 4 oC. The supernatant fluid from the first lavage was saved separately for the
determination of protein content and lactate dehydrogenase (LDH) activity using an automated
Cobas Fara II analyzer (Roche Diagnostic Systems, Montclair, NJ) with standard diagnostic
reagents and manufacturers procedures. Cell pellets from all lavage fluids of an individual rat
were combined and suspended in 1 ml of PBS to determine the total cell and differential cell
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counts using an electronic cell counter (Coulter Electronics, Hialeah, FL) equipped with a cellsizing unit (Lane and Mehta, 1990). Alveolar macrophages (AM) and granulocytes were
determined by their unique cell diameters and used in primary cell culture experiments.
LNC Preparation:
Lymph nodes (para-thymic and tracheal, and axiliary) were collected in 1 ml, pH 7.4,
Hepes buffer. The lymph node capsules were broken with a glass bar using a tissue culture
screen. LN cells were washed, transferred into a 15-ml tube, and centrifuged at 2000 rpm for 10
min. Cell pellets were reconstituted with 1 ml Hepes buffer for cell counts, cell differentiation,
flow cytometry, and cell culture experiments. The cell samples showed a lymphocyte content of
greater than 98%. Lymphocytes were used without further purification except for combined ITDEP and OVA exposure study. In this study lymphocytes were further isolated using
Histopaque® (d = 1.083, Sigma Chemicals, St. Louis, MO). In brief, the samples were
centrifuged for 30 min at 2500 rpm, and lymphocytes were collected, washed twice, and resuspended in 1 ml of Hepes buffer prior to assay.
Cell Cultures for Cysteine (CYSH) and GSH Synthesis in AM and Lymphocytes:
AM isolated from each rat were suspended in eagle minimum essential medium
(EMEM) culture medium (EMEM, Sigma Chemical Co.) containing 1 mM glutamine, 100 µg/ml
streptomycin, 100 units/ml penicillin, 10% heat-inactivated fetal bovine serum, and 10 mM
Hepes. Aliquots of 1 ml cell suspension, adjusted to 1 x 106 AM, were added to each well of a
12-well tissue culture plate. AM were allowed to adhere to the plastic plate for 2 h in a
humidified incubator (37 oC and 5% CO2) (Driscoll et al., 1990). The non-adherent cells were
removed by rinsing the monolayers three times with Hepes buffer. The AM-enriched cells were
then either analyzed immediately for CYSH and GSH content and GSH-R activity or further
incubated (37 oC and 5% CO2) in fresh Hepes buffer with, or without, cystine (24 µg/ml) for 16
hours. After centrifugation at 500 g for 5 min, the cell pellet was washed twice, resuspended in
1ml Hepes buffer, and analyzed for CYSH and GSH contents according to the following method.
One µl of a solution containing 80 mM monobromobimane (mbb) was added to 100 µl of the cell
suspension. The fluorescence derivitization of the reduced thiols was allowed to proceed at 4 oC
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overnight. The cells were then lysed by sonication for 30 seconds using a sonic dismembrator
(Fisher Scientific, Pittsburgh, PA), with a frequency of 20 Hz and an output of 40% max, 10
pulses (75 pulses/minute), on ice. Lysates were then centrifuged at 10,000 rpm for 10 min, and
filtered through a 0.2 µm filter (Microspin Nylon Filter, PGC, Frederick, MD) to remove cell
membranes and debris. Analysis of CYSH and GSH levels in the solution was carried out using
the reverse phase high performance liquid chromatography (HPLC) method described later.
For lymphocytes, aliquots of 2 x 106 cells were either analyzed immediately for CYSH
and GSH contents and GSH-R activity or further incubated with, or without, cystine (24 µg/ml)
for 16 h in a humidified incubator (37 oC and 5% CO2). Following incubation, cultures were
centrifuged at 500 g for 5 min and washed twice with Hepes. The pellets were re-suspended in
1ml Hepes buffer and analyzed for CYSH and GSH following the method described above.

BAL CELLULAR EVALUATION (GRANULOCYTES AND ALVEOLAR MACROPHAGES):
A Coulter multisizer II with AccuComp software (Coulter Electronics, Hialeah, Fl) was
used to quantify BAL granulocytes and alveolar macrophages.

BAL LDH, TOTAL PROTEIN, AND ALBUMIN DETERMINATION:
An automated Cobas FARA II (Roche Diagnostic Systems, Montclair, NJ) was used to
determine total acellular protein and LDH in BALF from the first wash. The protein content was
measured colorimetrically at 540 nm by using biuret reagent (Layne 1957) with Sigma
Diagnostic reagents and procedures (Sigma Chemical Company, St. Louis, Mo.). LDH was
measured by monitoring the formation of NADH spectrophotometrically at 340 nm using Roche
Diagnostic reagents and procedures (Roche Diagnostic Systems, Indianapolis, Ind.) and
expressed as units per liter according to the method described by Gay et al. (1968).
Albumin content in the acellular BALF from the first wash was monitored at 628 nm
based on the binding to bromcresol green. An automated Cobas Fara II analyzer (Roche
Diagnostic Systems, Montclair, NJ), and Sigma Diagnostic reagents and procedures (Sigma
Chemical Company, St. Louis, Mo.) were used. Results were expressed as milligrams per
milliliter BALF.
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THIOL CONJUGATION WITH MONOBROMOBIMANE (MBB):
Stock solutions of 80mM of MBB (Molecular Probe, Eugene, OR) were prepared in
acetonitrile. One ml of culture supernatant fluid, or live cell suspension (1-5 x 106 cells/ml) was
derivetized either for 2hr’s at room temperature or at 4CE overnight with 10ul of the MBB stock
solution. Following derivitization cells were lysed using an ultra sonic cell disruptor, centrifuged
(10000 rpm) for 10 min and supernatant fluid filtered through 0.2µm filter (Microspin Nylon
Filter, PGC, Frederick, MD) for subsequent HPLC/Fluorescent analysis.

GSSR AND CSSR HPLC MEASUREMENT
One microliter of 80mM Tributylphosphine were added to each 10µl sample. Samples then
incubated for 1 hr at 50CE. After cooling samples down, MBB were added following the abovementioned procedure. Samples were frozen at –20CE until ready for HPLC analysis.

HPLC CONDITIONS FOR GLUTATHIONE AND CYSTEINE DETERMINATION:
Preliminary Method:
Shimadzu ez chrom (VP version) HPLC system and RF-551 fluorometer detector were used.
Phenomenex (Luna, 5u) C18 column and a mobile phase of 11% Acetonitrile (ACN) and 89% of
1.5mM phosphoric acid-1.7mM acetic acid buffer (pH 2.7) with flow rate of 1ml/minute were
used for separation. Gradient of 11% ACN over 6 minutes to 15% over 10 minutes and 25% over
15 minutes and 35% over 18 minutes and then back to 11% over 21 minutes and then reequilibrated at 11% for 5 minutes (to 26 minutes). Glutathione and cysteine peaks were detected
with an excitation of 380 and emission of 480 with limits of detection of 1fmole.

Second Modified Method:
A Shimadzu HPLC system equipped with a RF-551 fluorometric detector and a C18 reverse
phase column (Phenomenex, Luna, 5 µm) was used for the analysis of CYSH and GSH.
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Separation of the mbb-thiol derivatives was achieved using a gradient system of acetonitrile in
0.1 M sodium acetate (pH 5.0), delivered at a flow rate of 1 ml/min. The gradient system
consisted of a mobile phase of 7 % acetonitrile for the first 6 minutes, and stepped increases to
15, 25, and 40% after 10, 15, and 18 minutes, respectively. The CYSH and GSH derivatives
were detected at an excitation of 380 nm and an emission of 480 nm, with retention times at 8.0
and 10.2 min, respectively.

CELL DIFFERENTIAL:
Slides were fixed with methanol for 5 minutes and dried. Slide staining were done by using
Diff-Quik Solution 1 (7 dips) and solution II (Baxter Healthcare Corp., McGaw Park, IL) (4
dips) and slide then washed with distilled water and dried.

FLOW CYTOMETERY:
To enumerate T cell subsets (CD4+ helper and CD8+ suppressor T-cells), each of the lymph
node cells were labeled with an appropriate monoclonal antibody, conjugated with a fluorescent
probe for visualization (Luster et al., 1988). Single cell suspensions were prepared from excised
lymph nodes. The cells were collected by centrifugation and suspended in phosphate buffered
saline, pH 7.4, containing 1% bovine serum albumin and 0.1% sodium azide to a cell density of
1.5x 106/ml. For the T cell subsets, the cells were incubated with 100 ml anti-rat CD4+
monoclonal antibody conjugated with PE (H 129.19, Pharmingen, San Jose, CA) and 100 µl of
anti-mouse CD8+ monoclonal antibody conjugated with PE (53-6.7, Pharmingen, San Jose, CA).
The cells were also incubated with their respective isotype control to correct for autofluorescence. After incubation with the conjugated monoclonal antibodies, the cells were
washed once with staining buffer and incubated for 5 minutes with 1mg/ml propidium iodide as
a viability stain. The cells were again washed and then enumerated on a Becton Dickinson
FacsVantage Flow Cytometer. Fluorescence was gated on propidium iodide to eliminate dead
cells. The values are expressed as the percent of gated live cells.
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FLUOROMETRIC IMAGING:
Cellular fluorometric images were taken by an Olympus AX7 microscope system with
epiflourescence by using filter cube in the UV range and excitation of 360-370 with barrier filter
of 420. The images were captured with a Sony DXC 9000 video camera.

TNF-" AND IL-1 MEASUREMENTS:
IL-1 in alveolar macrophage culture medium was analyzed using mouse thymocyte
proliferation assay (Kang et al., 1992). Briefly, thymocytes were obtained from male CD-1 mice
(6-10 weeks of age) and suspended in RPMI-1640 medium with 2mM glutamine, 100 U/ml
penicillin, 100 µg/ml streptomycin, 10% heat-inactivated fetal bovine serum, and 2 X 10-5 M
mercaptoethanol. Cells (1 X 106/0.1 ml per well) and aliquots (0.1 ml) of macrophageconditioned medium were added in quadruplicate to 96-well microculture plates. Cell cultures
were incubated at 37 ºC in an atmosphere containing 5% CO2 for 30 hours. The cultures were
pulsed for 22 hours with [3H] thymidine (1.0 µCi/well, activity 11.3 Ci/mmol; Dupont NEN
Products, Boston, Mass.), and the thymocytes harvested using a Harvester 96-cell harvester
(Tomtech, Orange, Conn.). The cell radioactivity in the collecting glass fiber filters was
measured using a liquid scintillation counter (1214 Rackbeta, Wallac, Finland). The amount of
IL-1 like activity in the tested macrophage supernatants was expressed as disintegrations per
minute. Antibodies of anti-rat IL-α and anti-rat IL-β (Endogen, Cambridge, Mass.) were used to
confirm IL-1 activity measured by the thymocyte proliferation assay. These antibodies
completely neutralized the activity in the macrophage-conditioned supernatant, thus indicating
that the increase in thymocyte proliferation was due to the presence of IL-1 in the macrophageconditioned culture medium.
TNF-α in macrophage-conditioned medium was determined using an enzyme-linked
immunosorbent assay (ELISA; Biosource International, Camarillo, Calif.) according to the
manufacturer’s instructions. ELISA was first described by Engvall and Perlmann (1971) and the
biotin-avidin system was described by Bayer and Wilchek (1978).
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GLUTATHIONE REDUCTASE (GSH-R) ACTIVITY:
The GSH-R activity was determined by measuring the reduction of GSSG to GSH. In
brief, a 200 µl sample was added to a cuvette containing 400 µl of 2.4 mM GSSG reagent
(Sigma Chemicals, St. Louis, MO) and 200 µl of 3mM 5,5’-dithio-bis(2-nitrobenzoic acid)
(DTNB, Sigma Chemicals, St. Louis, MO). At zero time, 400 µl of NADPH was added and the
rate of changes in UV absorbance, at 412 nm, over six minutes was recorded. The enzyme
activity was determined and expressed as µmole GSH/minute/million cells.

CYTOKINE REVERSE TRANSCRIPTION - POLYMERASE CHAIN REACTION (RTPCR):
IL-4 and INF-( mRNA normalized to G3PDH mRNA was measured using RT-PCR. The
RT-PCR experiments were carried out using the method of Noble (Noble et al., 1995). Total
RNA was extracted from lung and lung-associated lymph node (LALN) tissue by guanidine
isothiocyanate lysis (Trizol; Life Technologies, Rockville, MD). Tissues were processed
immediately after sacrifice. Reverse transcription was performed using 5 µg total RNA, oligo
(dT) 12-18 primers, and M-MLV reverse transcriptase (Superscript First-Strand cDNA Synthesis
Kit, Life Technologies, Rockville, MD).
PCR reactions were performed using cDNA derived from 0.4 µg RNA, primers listed
below, Taq polymerase (Sigma-Aldrich, St. Louis, MO), dNTP mix, 10x PCR buffer, MgCl2,
and H2O. The PCR conditions involved denaturation at 94oC for 30 sec, annealing at 55 oC for
30 sec, and extension at 72 oC for 90 sec. The initial cycle contained a 4-minute denaturation at
94 oC and the final cycle contained a 7-minute extension at 72 oC. 37 cycles were performed.
Primers

used

for

RT-PCR

were

as

follows:

IFN-γ,

5'

ATCTGGAGGAACTGGCAAAAGGACG-3' and 5'-CCTTAGGCTAGATTCTGGTGACAGC3’, which amplify a 288-bp fragment; IL-4, 5'-ACCTTGCTGTCACCCTGTTCTGC-3' and 5'GTTGTGAGCGTGGACTCATTCACG-3', which amplify a 352 bp fragment [23]; TNF-α, 5'TACTGAACTTCGGGGTGATTGGTCC-3' and 5'-CAGGCTTGTCCCTTGAAGAGAACC- 3',
which amplify a 295-bp fragment; IL-6, 5'-CAAGAGACTTCCAGCCAGTTGC - 3' and 5'TTGCCGAGTAGACCTCATAGTGACC-3', which amplify a 614-bp fragment; and G3PDH,
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5'-TGAAGGTCGGTGTCAACGGATTTGGC-3'

and

5'-

CATGTAGGCCATGAGGTCCACCAC-3', which amplify a 983-bp fragment. With the
exception of IL-4, all primer sequences were obtained commercially (Clontech, Palo Alto, CA).
PCR products were separated on 1.5% agarose gels in TBE buffer. Gels were stained
with ethidium bromide and digital images captured using a still video system (Eagle Eye II;
Stratagene, La Jolla, CA). For gels used to semiquantitate PCR product, samples were loaded in
volumes that equalized the size of bands for glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) PCR product as determined by visual inspection. Band densities of captured digital
images made from these gels were then quantified by densitometry (Eagle Eye II; Stratagene, La
Jolla, CA).

SERUM OVA SPECIFIC IGE AND IGG MEASUREMENTS:
Blood samples were collected from the vena cava at sacrifice. Four sera dilutions with
5% horse serum albumin (HOSA)/PBS of 1/100, 1/500, 1/1000, and 1/10,000 were analyzed for
OVA-specific IgE. The OVA-specific IgG determinations were obtained on sera dilutions of
1/10,000, 1/50,000, 1/100,000, and 1/500,000. Diluted sera (100ul) were added to a 96-well plate
(ICN Biomedicals, Inc., Horsham, PA) that had been previously coated with 200 µl of 1 % OVA
carbonate coating buffer and blocked with a 5% HOSA/coating buffer according to the method
of Voller and Bidwell, (1986). The plates were incubated overnight at 4 oC and subsequently
incubated with sheep IgG, anti-rat IgE (100 µl, 1/5,000 dilution in HOSA/PBS; Cat. No. 64-352,
ICN Biomedicals, Inc., Costa Mesa, CA) and horseradish peroxidase-bound donkey IgG, antisheep IgG (100 µl, 1/10,000 dilution in HOSA/PBS; Cat. No. 67541, ICN Biomedicals, Inc.,
Costa Mesa, CA) for 2 hr each at room temperature. The plates were washed three times
following each incubation. Plates were developed with tetramethylbenzidine (TMB, Sigma
Chemical Co., Saint Louis, MO), and read at 570 nm. OVA-specific IgG were determined using
Goat IgG, anti-rat IgG (1/1,000 dilution in HOSA/PBS; Cat. No. R5005, Sigma Chemical Co.,
Saint Louis, MO) and peroxidase-labeled rabbit IgG anti-goat IgG (1/25,000 dilution in
HOSA/PBS; Cat. No. A-3540, Sigma Chemical Co., Saint Louis, MO) as detection antibodies
following the same protocol described above. Pooled sera from sensitized rats to OVA was
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extensively tittered (Dilutions of 1/10,000 and 1/50,000 for IgE and IgG respectively was
assigned a value of 100) and concentration/response curves were obtained. These curves were
then used as references to obtain relative concentrations for the OVA-specific IgE and IgG of
different exposure groups.

DATA ANALYSIS:
All data were expressed as mean + standard error of 2-4 separate experiments. Each
measurement was run in duplicate or triplicate per experiment. Statistical analysis of data was
performed using Sigma Stat (version 2.0, Jandel Scientific Software, San Rafael, CA) statistical
software for Windows 95, NT, and 3.1. ANOVA (Tukey or Dunn’s), t-test, and Chi-square was
conducted and values of p < 0.05 were considered statistically significant.
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RESULTS
Thiols such as CYSH and GSH are presented in LNC and AM. The first step in our study
was to develop a HPLC method to detect and quantify specific thiols in LNC and AM at pmole
levels. The second step was to expose the rats to OVA, DEP, and Combined OVA and DEP and
study their effect on the thiol levels and the immune responses. Thus, this section will be divided
into five subsections in which the results of each study will be reported.

THIOL MEASUREMENT METHODS DEVELOPMENT
Lymph nodes (LN) (Axiliary and Tracheal) and Bronchial alveolar lavage (BAL) cells were
collected in 1ml of pH 7.4 (PBS+ 500mM BHT+ 50mM EDTA) from Sprague-Dawley, Hill Top
(250-275 gram) rats and used for the HPLC method development. As it has been mentioned in
methods section, monobromobimane (MBB) has been used as a thiol derivitizing reagent.
Bronchial alveolar lavage cells were >90% macrophages. Axiliary lymph node preparations
contained 70 to 80% lymphocytes, 15-20% macrophages and a few red blood cells.
Table 1 shows the levels of the CD4+ and CD8+ in the tracheal and para-thymic and axiliary
LN cells. Approximately 32% of the lymphocytes were CD4+ and 17%, CD8+ cells.
The uptake of MBB by alveolar macrophages and lymphocytes and the fluorescence
derivatization procedure were completed within two hours of incubation at room temperature
(Fig. 1). MBB reacted directly with intracellular thiols in intact live cells preventing oxidative
loss during lysis and filtration for subsequent HPLC analysis. The preliminary HPLC method has
been used in this study and the second modified HPLC method (which provided better peak
resolution) was used for all subsequent studies.
Standard curves with R = 0.998 were obtained by the HPLC analysis (Fig 2). The limit of
detection was less than 1 pmole/injection. The retention time for Cysteine and GSH were 6 and
10 minutes respectively (Fig 3).
Cysteine and GSH levels were determined in pooled tracheal and para-thymic (LNC),
and axiliary lymph node cells and alveolar macrophages of the Spraque Dawly rats (Table 2).
There were no big differences in the levels of CYSH and GSH between the axiliary and the
tracheal and para-thymic LN cells. The range of cysteine and glutathione from the axiliary lymph
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node cells were 80.9 to 92 and 123.1 to 195.98 pmole/106 cells, respectively, and tracheal
lymph node cells were 60.48 to 186.6 and 171.76 to 198.4 pmole/106 cells, respectively.
Cysteine and glutathione levels in the alveolar macrophages were 30, and 2.5 times higher than
lymphocytes, respectively. Comparison of total MBB induced fluorescence with
chromatographic total GSH and cysteine measurements suggest that these thiols constitute only a
small fraction to total cellular reduced thiol content.

OVALBUMIN DOSE RESPONSE STUDY
Granulocytes, LDH activity, total protein content, and albumin levels are shown in Figure
4. An OVA dose response relationship was seen for LDH, total protein, and albumin in BAL
fluid. These results show that exposure to high concentrations of aerosolized OVA causes
pulmonary epithelial damage and cell toxicity. However, the significance of these changes
depends on the OVA exposure concentration.
Figure 5 shows the dose response relationship between OVA and serum specific antibody
levels. There was a significant production of antigen-specific IgE and IgG in rats exposed to $
68 mg/m3 OVA. The same trend of increases was seen in the specific IgG levels (Panel B).
Dose-dependent tolerance was noted in the production of OVA-specific IgE.
The levels of cysteine and GSH were determined in bronchoalveolar lavage fluids (Figure
6). Both cysteine and GSH levels were increased significantly (50 times, at the highest exposure
dose) with increasing dose.
The effects of OVA sensitization and challenge on cellular concentrations of cysteine and
GSH were studied in AM and lymphocyte taken immediately after sacrifice. Figure 7 shows the
intracellular cysteine and GSH levels in AM from various exposure groups. Cysteine at the
lowest OVA exposure dose increased slightly followed by a sharp decrease (~ 10 times) at the
higher OVA exposure doses. Glutathione levels were increased slightly at 7.2 mg/m3 and
significantly (1.25 times) at 68 mg/m3 dose. A marked decrease (10 times) in the Glutathione
levels was seen at higher OVA exposure doses.
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Figure 8 shows the cysteine and glutathione levels in LNC. There was a significant
increase (~ 1.6 times) in the cysteine levels at high OVA exposure doses. Glutathione levels in
these cells were not changed.
Both AM and LNC were incubated for 16 hr’s (ex-vivo) in thiol free medium to study
their ability to regulate the CYSH and the GSH levels. AM from OVA exposed (93 mg/m3 and
higher) animals showed a significant increase in the intracellular levels of both CYSH and GSH.
In contrast, these cells showed a significant reduction in the extracellular levels of both CYSH
and GSH (Fig 10). LNC showed the same trend of behavior when incubated in the same thiol
free medium (Fig 11).

COMPARISON

OF

PULMONARY

RESPONSE TO INHALED AND INTRATRACHEALLY

INSTILLED DIESEL EXHAUST PARTICULATE.
Chamber samples of both DEP and CB revealed similarities in shape and size between
them when examined microscopically (Fig. 13). DEP collected from an environment in which a
diesel engine was in use has a fluffy appearance by electron microscopy. In comparison, DEP
retained into the air in the laboratory appeared a little more compact. Our analyses for the
generated particles also showed that more than 90% of the particles generated were in the
submicron range (data not shown).
The effect of IT-DEP on the levels of glutathione (GSH) and cysteine (CYSH) in both
BAL cells and LN cells were studied at 4, 24, and 72 hours (Fig 14). Both GSH and CYSH
levels in BAL cells were increased significantly at all time points. Concurrently, the increase in
the GSH levels in LN cells was seen at 24 and 72 hours but not at 4 hours post IT-DEP exposure.
The inflammatory markers represented by PMN, LDH, and total protein was also studied
(Fig. 15). IT-DEP exposure caused pulmonary inflammation in the lung at 4 hours following
exposure as noted by the increase in neutrophils count. This inflammation was also manifested
by a significant increase in lavage and LDH proteins.
TNF-" and IL-1 were determined in AM cultured medium with, and without, ex vivo
LPS stimulation (Fig. 16). One day post IT–DEP exposure a significant increase in the level of
TNF-" was noted. TNF-" was also enhanced in LPS stimulated mac’s from DEP exposed rats
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vs LPS stimulated control rat mac’s. At three days post IT-DEP exposure a significant decrease
of AM TNF-", after ex vivo endotoxin challenge, was observed. Interlukin-1 was significantly
elevated in IT-DEP from saline control group at both 1 and 3 days post exposure. In addition,
LPS stimulation caused an enhanced increase in the IL-1 levels of the AM at 1-day post IT-DEP
exposure.
Table 3 contains a comparison of lymph node and BAL cells at 72 hours post either IT or
inhaled DEP exposure. Inhaled DEP caused a significant increase in the levels of GSH in the
LNC. CYSH, but not GSH increased significantly in the BAL cells. Both inhaled and IT DEP
exposure caused a significant decreases in the AM TNF-" levels after ex vivo endotoxin
challenge. The major difference between IT and inhalation routs of exposure is that inhaled DEP
did not cause a measurable pulmonary inflammatory response.

ALTERATION

OF

INTRACELLULAR CYSTEINE

AND

ALVEOLAR MACROPHAGES AND LYMPHOCYTES

BY

GLUTATHIONE LEVELS

IN

DIESEL EXHAUST PARTICLE

EXPOSURE
Figure 17 shows the pulmonary inflammatory responses to DEP exposure. A timedependent increase in neutrophil infiltration, LDH level, total protein and albumin content in the
lavage fluid was noted. The neutrophil count peaked (6-fold over control) by 24 hours and was
still elevated at 72 hours following exposure. Significant lung damage, as indicated by BALF
LDH activity, protein, and albumin content, was observed at 4, 24 and 72 hours post exposure.
Changes in intracellular CYSH and GSH in AM and LNC, in relation to the saline control, are
shown in Figure 18. In response to DEP exposure, AM had an acute elevation in CYSH (10-fold)
and GSH (3-fold) levels (at 24 hours post exposure), which was still elevated at 72 hours post
exposure.

In comparison, CYSH in LNC was increased starting at 4 hours and remained

elevated at 24 and 72 hours post DEP exposure. There was a delay in the increase of GSH levels
in LNC with a peak concentration (1.5-fold over control) at 24 hours. The elevation of the GSH
level in DEP-exposed lymphocytes declined toward control values by 72 hours post exposure.
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Figure 19 shows the effects of DEP exposure on the capacity of AM to generate CYSH
and GSH from cystine. Cells from rats exposed to IT-DEP or saline for 72 hours were incubated
ex vivo with 24 µg/ml cystine for 16 hours. In saline-exposed cells, the CYSH level was
increased 6-fold over the control by the presence of cystine, indicating that AM exhibit a strong
capacity to take up cystine and reduce it to CYSH. DEP exposure enhanced AM capacity to
convert cystine to CYSH (panel A). The addition of cystine (in DEP-exposed AM) resulted in a
10-fold increase in the cellular level of CYSH. The level of GSH in AM from control rats was
not affected by ex vivo incubation with cystine for 16 hours despite of the increase in CYSH, but
was significantly increased by DEP exposure, particularly in the presence of cystine (panel B).
These results show that although CYSH is required for the synthesis of GSH, increased level of
intracellular CYSH did not necessarily result in greater GSH levels in cells from saline exposed
control animals at this 16 hour time point. The cells from DEP-exposed rats, on the other hand,
exhibited increased uptake and conversion of cystine to CYSH and significantly elevated GSH
level, suggesting an enhanced GSH synthesis.
Figure 20 shows the effects of DEP exposure on the thiol regulation in LNC. The ex vivo
incubation with cystine resulted in a 2-fold increase in CYSH production, suggesting that these
cells have the capacity to take up and convert cystine to CYSH. In comparison, the DEP
exposure resulted in a 6-fold enhancement of CYSH production in LNC. This response was
further augmented by the addition of cystine (panel A) to the culture medium. Panel B shows
that the GSH levels in LNC were not affected by ex vivo cystine, but were significantly reduced
(60 %) by the DEP exposure when cultured for 16 hours in thiol free media.
The possibility that DEP may affect solution concentrations of various thiols through
particle absorption was investigated. Figure 21 shows that DEP exhibited relatively strong
affinities toward cystine, moderate absorptive capacity toward CYSH and GSH, but no effect on
GSSG. DEP did not directly alter glutathione reductase activity (data not shown).
Figure 22 shows the effect of DEP on the glutathione reductase (GSH-R) activity in AM
(panel A) and lymphocytes (panel B). Cells from rats exposed to saline or DEP for 72 hours
were used. The GSH-R activities in DEP-exposed AM and lymphocytes were found to be 1.8and 4.0-fold that of the saline controls, respectively.
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Since the Brown Norway rats have been extensively used as a model for allergic
sensitization, we have carried out similar studies to evaluate thiol changes in the Brown Norway
rat model. Table 4 show the comparison of DEP-induced inflammatory responses in the SpragueDawley and Brown Norway rats. These results show that while they differ in magnitude, both rat
models show similar trends of inflammatory responses to DEP exposure. Thiol regulation also
showed similar trends in both strains. It is interesting to note that DEP thiol alteration in the AM
of SD rats was notably much greater than that seen in AM from the BN rats.

THE EFFECT OF DIESEL EXHAUST PARTICLES (DEP)

AND

CARBON BLACK (CB)

ON THIOL CHANGES IN PULMONARY OVALBUMIN ALLERGIC SENSITIZED BROWN
NORWAY RATS.
Brown Norway rats were exposed by IT to either DEP or CB on day zero followed by
OVA sensitization and challenge as described earlier. Figure 23 shows that rats, at four weeks
post IT exposure to DEP or CB alone, exhibit normal levels of total protein and LDH in the BAL
fluid, as compared to the saline control. Rats exposed to OVA for four weeks also exhibit
normal levels of total protein and LDH in the lavage fluid. These results show that OVA or the
particles alone did not cause persistent pulmonary epithelial damage or cell toxicity. There was
also no increase in BAL inflammatory cells in these groups. In the combined exposures with
OVA, however, both DEP and CB resulted in significantly elevated levels of inflammatory cells,
total protein and LDH as compared to OVA or particle exposure alone, indicating that both DEP
and CB aggravated the airway allergic inflammatory responses to OVA.
Figure 24 shows the effect of DEP or CB on OVA-induced serum specific antibody
levels. An antigen-specific IgE and IgG antibody responses in rats exposed to OVA alone were
found, and a marked enhancement in antibody production in rats exposed to either particles
(DEP or CB) or OVA. The increase in anti-OVA IgE production due to particle interplay was 4
and 3.5 fold that of the OVA control for the CB- and DEP-exposed groups, respectively. The
increase in serum anti-OVA IgG production by CB or DEP was 5 – 6 fold higher than OVA
exposure alone. These results show that both DEP and CB exhibit adjuvant effect on OVA
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sensitization, and that particle composition, in this case the organic content in DEP, is not
critical in inducing the adjuvant effect.
Figure 25 shows the effect of CB or DEP on IFN-γ and IL-4 (panels A and B) mRNA
expressions in lung tissues of non-sensitized and OVA-sensitized rats. In non-sensitized animals,
both DEP and CB appear to enhance IFN-γ mRNA content as compared to saline controls, but
this enhancement was not statistically significant. In contrast, there is a significant increase in
IL-4 mRNA by DEP exposure. OVA-sensitization alone did not alter IFN-γ and IL-4 mRNA
levels in the lung tissue. In the combined exposures, while the IFN-γ mRNA levels remain
unchanged in all groups, both CB- and DEP-exposed rats showed elevated levels of IL-4 mRNA
when compared to rats exposed to OVA alone. The enhancement of IL-4 mRNA by DEP is
significant and is consistent with the fact that DEP alone induced an increase in IL-4 mRNA in
lung tissue. There was no significant difference in TNF-α mRNA in lung tissue of all exposure
groups (data not shown).
The effects of particle and OVA exposures on cellular concentrations of CYSH and GSH
were studied in AM and lymphocyte primary cultures incubated for 16 hr in thiol free medium.
Figure 26 shows the intracellular CYSH (panel A) and GSH (panel B) levels in AM from various
exposure groups. DEP or CB exposure alone did not alter the thiol levels at four weeks post
exposure. The OVA exposure slightly increased the CYSH concentration, but markedly
decreased the intracellular GSH concentration. In the combined exposure, AM from all groups
exhibited elevated concentration of CYSH, but lowered GSH, when compared to the saline
control. Figure 27 shows that DEP or CB exposure alone did not significantly affect either
CYSH or GSH levels in lymphocytes. Exposure to OVA, on the other hand, resulted in a
substantial decrease in both CYSH and GSH concentrations. Figure 27B also shows that DEP
may augment the OVA effect in lowering the intracellular GSH in lymphocytes. The difference
in effect of OVA challenges to sensitized rats between this study and the OVA dose-response
study is addressed in the discussion.
The abilities of AM and lymphocytes from various exposure groups to utilize cystine in
CYSH and GSH synthesis are shown in Figures 28 and 29, respectively. Alveolar macrophages
had a strong capacity for the uptake and conversion of cystine to CYSH (Figure 28A). This
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ability, however, was significantly suppressed by OVA exposure. Both DEP and CB exposures,
on the other hand, enhance CYSH production by AM, even in cells from OVA-sensitized rats.
The addition of cystine to AM culture did not result in a significant increase in GSH synthesis in
all exposure groups (Figure 28B). GSH was not assessed in the extracellular medium and it is
possible that the AM transported much of the GSH out of the cell. Figure 28B further shows that
OVA decrease GSH concentration in AM. Figure 29A shows that lymphocytes have the capacity
to take up and convert cystine to CYSH. This capacity was not significantly altered by DEP or
CB exposure, but was strongly inhibited by OVA. The addition of cystine to lymphocyte culture
resulted in a slight increase in GSH synthesis in all exposure groups. As shown in Figures 26 and
27, OVA exposure resulted in lowered cellular levels of GSH in AM and lymphocytes. Figures
28 and 29 further show that even under elevated concentrations of CYSH (through cystine
utilization), the GSH levels in AM and lymphocytes remain suppressed by OVA sensitization
and challenge.
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DISCUSSION
This study has been divided to four subsections in order to discuss each section in more
detailed way. Our objectives were to study the effect of animal sensitization (with OVA), DEP
exposure, and combined DEP and OVA exposure on the thiol (GSH and CYSH) levels and the
consequences of this effect on the pulmonary immune responses. A comparison between IT- and
Inhaled-DEP exposure was also included to show the difference in the effect on thiols when
exposed by these two routs. In the following sections each of these exposures will be discussed
according to its appearance in the result section:

NEW HPLC METHOD FOR THIOLS
Many published methods exist for the measurement of thiols in their oxidized and
reduced forms (Cysteine and Glutathione) from different biological samples. Many of these
methods are either non specific or not sensitive enough to detect the low levels of the thiols in
biological samples.
A rapid and sensitive method for the quantification of CYSH and GSH in intact macrophages
and lymphocytes and of intracellular cysteine and GSH levels via HPLC was developed.
Monobromobimane (MBB) has been used as a label for both protein and non protein thiols by a
glutathione S-transferase-independent mechanism. MBB penetrates the cellular membrane and
reacts with the cellular-thiols in live intact cells. Cellular (macrophages and lymphocytes)
cysteine and glutathione content were easily derivetized with MBB and the resultant
fluorescence was detected by a newly developed HPLC method. The HPLC method has a limit
of detection of less than 1 pmole/injection. Both reduced and total (reduced plus oxidized forms)
free CYSH and GSH levels can be measured in intact cells directly by this method. Some major
advantages of our method include; (1) Simultaneous measurement of both CYSH and GSH, (2)
No loss of reduced form during processing of tissues for thiol measurement, (3) Production of a
stable derivative that can be stored for later analysis, and (4) Measurement of total GSH includes
reduced plus all G-S-S-R forms, including membrane bound, protein and non-protein species.
Total CYSH determination has the same advantage. Most other methods only include acid
soluble thiols in their measurements.
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OVA SENSITIZATION AND CHALLENGE DOSE-RESPONSE
Allergic sensitization due to occupational exposure to egg protein has been reported
(NIOSH, 1988). Immune response changes due to antigen (such as OVA) exposure have been
connected to thiol changes in the cell and its surrounding environment. A direct relationship
between T cell GSH levels and T cell function has been reported in GSH depletion experiments.
Suppression of T cell activation (Droge et al., 1991; Kavanagh et a., 1993; Staal et al., 1994;
Otsuji et al., 1996; Wilhelm et al., 1997; Potter et al., 1997), proliferation (Fidelus et al., 1987;
Suthanthiran et al., 1990; Gmunder et al., 1990; Smyth 1991; Walsh et al., 1995; Taylor et al.,
1997), level of IL-2R expression (Liang et al., 1992), cytokine production (Peterson et al., 1998;
Lawrence et al., 2000), and the generation of CTL responses (Gmunder and Droge 1991;
Multhoff et al., 1995) have been reported.
We used Brown Norway rats to investigate the effect of a wide range of OVA exposure
and challenge concentrations (7-156 mg/m3) on thiol levels and antibody (Th2) production.
Dose-dependent effects of the aerosolized OVA on inflammatory markers (LDH, total protein,
and albumin) were seen (Fig 4).
Because it is required for the reduction of disulfide bonds, GSH if depleted has been
shown to impair the ability of APC (such as AM) to process and present antigens, which are rich
in cystine (Gainey et al., 1996; Short et al., 1996). In this regard, our results show a severe
depletion in both CYSH and GSH levels in AM (Fig 7). This depletion was concomitant with the
biphasic IgE serum titer. A threshold of these changes could be recognized in the thiol levels in
BAL and AM. These results were in agreement with Fahy et al., (2000) who reported that DEPs
and allergens could result in high local chemokine levels via MAP kinase pathways activation in
allergic patients. This in turn could increase the likelihood of reaching a critical threshold leading
to the initiation of respiratory allergic symptoms. Our results show that exposure to allergen
alone (such as OVA) in high levels (68 mg/m3 and higher) were needed to reach this threshold
and cause the initiation of allergic symptoms.
It is interesting to note that allergic challenge of sensitized BNR cause a large increase in
BAL fluid CYSH and GSH (Fig 6) even though alveolar macrophage thiol levels were severely
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depleted (Fig 7) and the AM attempting to conserve the remainder of their intracellular thiols
(Fig 10). In addition, our previous work showed that OVA exposure at 90 mg/m3 impaired the
ability of AM in taking up the ex vivo supplemented cystine and using it as a thiol source (AlHumadi et al., 2002-2). Together these results suggest that AM were not the source of the BALF
thiols. The reduction of the thiols in AM starts at the 68 mg/m3 and was reduced even more at the
93 mg/m3.
An increase of cysteine in LNC (Fig 8) is needed to maintain the levels of GSH, required
for T-cell proliferation and differentiation after the antigenic stimulation (Wilhelm et al., 1997;
Fidelus et al., 1987; Suthanthiran et al., 1990). LNC tended to conserve thiols intracellularly
when incubated ex vivo for 16 hr’s (Fig 11). LNC response to high OVA exposure was different
than that of AM as an increasing in the total (intra- and extra- cellular) GSH was noted (Fig 11).
Even though cysteine levels were significantly increased in LNC, our previous results shows that
these cells lost its ability in taking up cystine and reduce it to cysteine (ex vivo) after exposure to
OVA (Al-Humadi et al., 2002-2). In addition, the same study showed the reducing ability of
these cells in increasing the GSH level. Methodology may also be very important in assessing the
thiol response in LNC. At high OVA challenge an increase in LNC thiols was noted in this study
(Fig 8). The LNC were used directly after breaking the LN capsule, without further purification.
A sever loss of thiols from LNC of OVA sensitized and challenged BNR was noted in a
subsequent study. The major difference between the two experiments was that LNC were
processed with ficoll hypague prior to use in the latter study. The sensitized LNC may have been
hyper reactive, causing a loss of thiols when placed in this hyperosmotic environment.
Both OVA specific IgE and IgG sera levels were dose-dependent. The IgE response was
biphasic, with the development of tolerance at the higher doses (Fig 5). Cytokine production in
response to Th1-associated, but not Th2-associated antigens, was reported to be selectively
inhibited with GSH depletion (Peterson et al., 1998). The relationship between thiol and immune
regulation may be very complex. As noted with the alveolar macrophage, one cell type may
become dysfunctional with respect to its thiol regulation, even while it’s surroundings become
thiol rich. Allergic sensitization is a multifactorial, pleocellular process. It cannot be determined
if the AM reflects all APC’s or if it is atypical since they exist outside the body in alveolar
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spaces. It is interesting to note, however, the parallel occurrence of AM thiol regulation
dysfunction and IgE tolerance in this study.
Antibody production requires the activation of the kB nuclear factor (NFkB). Both high
and low levels of GSH affect the process of activation (Droge et al., 1994). A cascade of
membrane-bound and cystoplasmic protein kinases including tyrosine kinases of the src family
are required to trigger the activation of NFkB (Finco and Baldwin 1993; Schicven et al., 1993;
Hayashi et al., 1993). P56lck(associated with CD4+ and CD8+ molecules and IL-2 receptor Bchains) and P59fyn (associated with T cell receptor/CD3 complex),(both are members of the src
family)were found to be activated by thiol oxidizing agent diamide (Schicven et al., 1993;
Hayashi et al., 1993; Nakamurz et al., 1993). The activation of both tyrosine kinases have to be
by cross-linking of the corresponding surface receptor molecules and plays an important role as
signal transducing molecules in T cell-mediated immune responses. A reactive cysteine residue,
the active site of protein tyrosine-phosphatases, must be in the reduced form for catalytic activity
(Stevens and Jones 1989). These are some of the important roles that thiol plays in the activation
of an immune response. The initial increase followed by the severe reduction in CYSH and GSH
levels in AM might explain the biphasic IgE response in our results.
The correlation between CYSH levels and antibody (IgE) production were analyzed (Fig
9). The highest correlation were found between CYSH in BAL and AM (R = 0.96 and = 0.91,
respectively) and IgE production. This might be an indication of the dependence of IgE (which is
part of the humoral immunity) production on the CYSH level changes happening in the lungs.
The ability of both AM and LNC in maintaining the optimal levels of CYSH and GSH in
the intra- and the extra- cellular environment were studied (Figures 10 and 11). OVA-exposed
AM tended to keep all the thiols intracellularly, when incubated for 16 hr’s in thiol free medium,
despite the fact that the basal level of these thiols was reduced significantly. LNC increased their
levels of CYSH. They also conserved CYSH and GSH over control cells as noted by the percent
released to the culture media during a 16 hr incubation.
AM and LNC tendency to conserve thiols intracellularly might be a measures to delay or
prevent apoptotic initiation. It has been reported that Fas-mediated apoptosis is modulated by
intracellular glutathione in human T cells (Chiba T., et al., 1996). Potentially thiols may be
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shifted to the mitochondrial compartment (a non-releasable pool) (Gainey et al., 1996) as a
measure of preventing cytochrome C from being released and thus preventing apoptotic
initiation.
Two steps are required to breakdown GSH extracellualrly and this process will be catalyzed
by (-glutamyl transpeptidase and dipeptidase. As a result the GSH will be degraded to its
constituent amino acids and made available for the (weak GSH uptake) cells. Our results show
that AM and LNC transferred the GSH to the extracellular space without the need to break it
down. Whether they transferred GSH was by exocytosis or by a special tripeptide transporter
system is not clear yet. The overall conclusions are:
1- IgG antibody displayed a dose dependent increase while the IgE response is biphasic (Fig
5), within the exposure range and time employed.
2- In vitro studies suggest that the dose dependent increase in BAL thiols was not
dependent on alveolar macrophages thiol regulation (Fig 6).
3- Dose dependent loss of alveolar macrophage ability to regulate thiols (Fig 7) was
suggested by; a- loss of intracellular CYSH and GSH in AM, b- decrease ability to take
up and reduce thiols (Al-Humadi et al., 2002-2), and c- decrease in secretion of thiols
(Fig 10).
4- Increase in lymphocyte CYSH at higher OVA exposure to sensitized rats was possibly
due, at least in part, to conservation of intracellular thiols (Fig 8).
5- The relationship between antibody responses to inhaled antigens and thiol changes in the
lung is not clear. If there is any, this relationship could be indirect through the effect of
thiols on signal transduction (e.g. NFkB) as suggested by other studies.

COMPARING IT- AND INHALED-DEP EXPOSURES
Pulmonary inflammation as noted by influx of PMN, and increases in BAL LDH, protein
and albumin levels was found following IT-DEP, but not inhaled-DEP. Both IT and inhaled-DEP
caused a significant increase in intracellular thiol levels in LN and BAL cells 72 hrs following
exposure. Inhaled CB did not produce significant changes in parameters measured.

34

Exposure of rats to DEP by IT caused significant decrease in TNF-α production by AM
in response to LPS stimulation, but LPS stimulated TNF-α production was not decreased by
inhaled DEP 72 hrs following exposure.
Intratracheal and acute inhalation exposures are difficult to compare due to the
differences in distribution, deposition, and internal dose, any or all of which may have
contributed to the differences noted above.

STUDYING THE EFFECT OF IT-DEP
IT-DEP exposure is known to induce pulmonary inflammation, including elevated levels
of neutrophils, LDH, and total protein in the airways (Yang et al., 1999; Al-Humadi et al., 20021). These increases have been associated with increased production in oxygen free radicals in the
alveolar space (Hiura et al., 2000). Alveolar macrophages from DEP-exposed rats show
decreased response to lipopolysaccharide and bacterial stimulation in the production of IL-1 and
TNF-α (Yang et al., 1999; Yang et al., 2001), suggesting that DEP can alter innate immune
responses, which may lead to increased susceptibility to bacterial infection. In addition, several
recent studies have linked DEP exposure to allergic inflammation (Saxon and Diaz-Sanchez,
2000; Rudell et al., 1999; Nordenhall et al., 2000; Fahy et al., 2000) and increased IgE
production (Diaz-Sanchez et al., 1994). Other studies have shown that DEP exposure promotes
isotype switching to IgE in humans (Fujieda et al., 1998) and in animals (Muranaka et al., 1986).
Together, these studies indicate that DEP may suppress cellular, but enhance humoral pulmonary
immune responses.
The present study is consistent with the concept that CYSH and GSH may play a dual
role in DEP-induced pulmonary immune/inflammatory responses. The increase in CYSH and
GSH levels in AM (Figure 18) appears to be an acute response to DEP exposure. As
antioxidants, these molecules are produced and secreted by AM and other cells to protect the
lung from particle-induced oxidative stress and injury. Interestingly, our results showed that
DEP are capable of absorbing cystine and CYSH and possibly altering the extracellular thiol
balance through a non-inflammatory mechanism. During the inflammatory process, oxidized
thiols such as cystine may be internalized by AM and converted to CYSH. The fact that the DEP
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induces GSH-R activity in AM (Figure 22) is also consistent with an increased production of
CYSH. The DEP exposure also resulted in a significant increase in AM production of GSH at 24
hours post-exposure, and a persistent increase of GSH levels at longer post-exposure times (72
hr). The effect of DEP on GSH in AM (ex vivo) may be attributed at least in part to increased
GSH-R activity.
As shown in Figure 18, the GSH level in LNC was increased at 24 hours and declined at
72 hours post DEP exposure. When cultured ex vivo, LNC from DEP exposed animals had a
significant decrease in GSH. In comparison to AM, there was a delayed increase in GSH level in
LNC and no increase in GSH from control LNC cultured with cystine. In all cases lymphocytes
were the predominant (> 95%) LNC. These data suggest that lymphocytes may depend on
extracellular GSH released from cells such as macrophages.
To provide more insight into the DEP effects on cellular regulation of thiols, AM and
lymphocytes from saline and DEP-exposed animals (72 hrs post exposure) were isolated and
tested for their reduction of CYSH and production of GSH (Figures 19 and 20). These results
show a clear difference between AM and lymphocytes in their responses to DEP exposure.
Alveolar macrophages exhibited a strong capacity in the uptake and conversion of cystine to
CYSH (Figure 19). This is in line with the results reported by Watanabe and Bannai, (1987).
They showed that macrophages exhibit strong membrane transport activity for cystine uptake
and are capable of releasing reduced thiol into the extracellular space. DEP exposure increased
AM production of CYSH and GSH two-fold.

AM from rats exposed to DEP showed a

significant increase in GSH-R activity (Figure 22). The DEP exposure did not affect the
intracellular level of CYSH in the absence of (added) cystine, but a moderate increase in GSH
levels were observed. The mechanism that DEP induces an increase in intracellular GSH levels
is not yet clear, but the enhancement of GSH-R activity appears to play a major role in AM
responses to DEP exposure. In the presence of cystine, the intracellular levels of CYSH and
GSH in DEP-exposed cells were markedly higher than the controls, which can be attributed
primarily to increased production of CYSH through increased GSH-R activity.
In lymphocytes, the DEP effect on thiol regulation was quite different from that observed
in macrophages. These cells exhibited a moderate capacity in the uptake and conversion of
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cystine to CYSH. Studies by Ishii et al., (1987) have shown that lymphocytes exhibit strong
membrane transport activity for CYSH, but only a weak transport activity for cystine. Unlike its
effect on AM, the DEP exposure strongly increased the level of CYSH in LNC with or without
added cystine. This may be in part due to the fact that DEP also induce GSH-R activity in these
cells (Figure 22). It is possible that DEP-exposed lymphocytes contain oxidized thiols that were
produced during the exposure. These compounds were subsequently reduced to CYSH through
increased GSH-R activity. But, despite the increase in CYSH level and GSH-R activity, the
intracellular concentration of GSH in lymphocytes was significantly decreased by DEP exposure
when cultured ex vivo. The mechanism by which DEP depletes GSH in lymphocytes is not yet
clear. DEP may have increased catabolism of GSH by the lymphocyte, which was not able to
replenish its intracellular stores when cultured in thiol free media.

These possibilities are

currently under investigation.
It is known that GSH levels affect the activation of NFkB (Droge et. Al., 1994; Haddad et
al., 2000), and that DEP exposure could alter the function of this important intracellular
messenger. DEP exposure has been linked to increased IgE production (Diaz-Sanchez et al.,
1994) and isotype switching in B cells to produce IgE in human (Fujieda et al., 1998) and in
animals (Muranaka et al., 1986). The cellular activity of GSH in regulating B cell functions has
not been studied in detail. It is likely, however, that GSH may play an important role in the
alteration of both cellular and humoral immune responses by DEP exposure. The BN rat strain
which is noted for its Th2 (IgE) phenotypic responses was compared to SD rats. The pattern and
magnitude of the inflammatory response to DEP was similar. The thiol response pattern was also
similar but the magnitude of the AM-thiol increases after DEP exposure was drastically greater
in the SD rats. It is not known if the strain difference in the magnitude of the AM-thiol response
is related to differences in antibody isotype production.
In summary, the present study shows that AM and LNC responded to DEP exposure with
alteration in their thiol metabolism. Exposure to DEP increased the GSH-R activity of AM and
LNC, and thus, increased level of CYSH. The intracellular level of GSH in DEP-exposed AM
was moderately increased when compared to the saline control, and was further augmented when
cells were incubated with cystine. Lymphocyte from DEP exposed rats also showed a significant
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increase in GSH, but in contrast to AM, DEP exposed lymphocytes were not able to maintain or
replenish their GSH when cultured in GSH free media indicating that DEP exposure may
decreases either lymphocyte production or uptake of GSH. Other possibilities such as increases
GSH catabolism or shunting CYSH to other synthetic pathways such as antibody synthesis
should also be considered.

COMBINED IT-DEP AND INHALED-OVA EXPOSURE EFFECT
Exacerbation of respiratory allergy has long been associated with particulate air pollution
exposure. DEP, which consist of carbonaceous particles and aromatic and aliphatic hydrocarbons
adsorbed onto the particle surface, is a major air borne pollutant. Both the particulate and the
organic components may play a role in their biological effects. Studies have already indicated
that DEP induce acute pulmonary inflammatory responses, but suppress AM responses to
lipopolysaccharide and bacterial stimulation in the production of nitric oxide, IL-1, and TNF-α,
thus increasing the susceptibility of the lung to respiratory infection (Yang et al., 1999; Yang et
al., 2001). This effect was attributed to the organic component of DEP. The adjuvant effect of
DEP through intranasal administration on allergic sensitization has been reported in humans and
in mice (Saxon and Diaz-Sanchez, 2000; Rudell et al., 1999; Nordenhall et al., 2000; Fahy et al.,
2000). This effect was characterized by an increase in antigen-specific IgE production (DiazSanchez et al., 1994), and the secretion of Th2-type cytokines in the nasal mucosa (Diaz-Sanchez
et al., 1997). Recent studies further indicate that carbonaceous particles such as CB also
stimulate Th2 responses and exhibit adjuvant activity to allergic sensitization (Van Zijverden et
al., 2000). Indeed, through the present study, we have demonstrated that both carbon black and
DEP aggravated OVA-induced pulmonary allergic inflammatory responses (Figure 23), enhance
anti-OVA IgE and anti-OVA IgG production (Figure 24), and cause an increase in IL-4 mRNA
expression in lung tissue (Figure 25). These results suggest that particle composition of diesel
exhaust does not play a major role in the adjuvant effect.
CB was found to exhibit similar effects to those of DEP on IFN-γ and IL-4 mRNA tissue
levels. The mRNA level of IFN-γ was not significantly affected by CB, DEP, OVA, or combined
particle-OVA exposure. Thus, it is inconclusive whether DEP or CB affects the production of
38

IFN-γ or other Th1 cytokines in the lung. It should also be mentioned that at four weeks post
particle exposure, animals were well recovered from the acute inflammatory stimulation by these
particles, however the tissue cytokine message levels were examined 24 hr’s after OVA
challenge of sensitized rats. In contrast, DEP and CB exposure, even at four weeks post
exposure, resulted in elevated levels of IL-4 in lung tissues from either non-sensitized or OVAsensitized rats (Figure 25), although the data on CB did not reach statistical significance in the
current experiments. Nevertheless, these results indicate that DEP or CB may augment OVAinduced antibody production through enhanced Th2 responses (i.e., IL-4 production). These
results are consistent with those of other studies indicating that DEP enhances IL-5 production
and IL-4 mRNA level in OVA-sensitized mice (Takano et al., 1997).
The cellular mechanism(s) involved in altered immune response and cytokine production
remains unclear. The fact that rats exposed to DEP or CB showed a significant increase in lung
damage and inflammation, when further challenged with OVA suggests potential alteration in
cells, such as AM and lymphocytes, involved in the immune response. For this reason we have
studied the role of CYSH and GSH in pulmonary allergic responses associated with particle,
OVA, and the combined particle-OVA exposures. Thiols are important molecules for various
lymphocyte functions. Depletion of intracellular GSH inhibits the lectin-induced activation
response of T lymphocytes (Hamilos et al., 1991). Studies by Gmunder and Droge, (1991)
showed that depletion of intracellular GSH decreases the proportion of CD8+ cells (i.e., it
increases the CD4+/CD8+ ratio), and inhibits the generation of large blast-like CD8+ cells and
cytotoxic T lymphocyte activity. CYSH has a strong influence on the intracellular GSH and
DNA synthesis of cytotoxic T cell clones (Gmunder et al., 1990). Thiols in fact may play a
regulatory role analogous to the hormone-like lymphokines and cytokines in mediating
immunologically relevant functions of lymphocytes. Our initial study demonstrated that DEP
produced a time dependent increase in GSH and CYSH levels in AM and lymph node
lymphocytes which peaked at 4 and 72 hrs post exposure, respectively. Thiol reductase activity
was also induced by DEP (Al-Humadi et al., 2002-1). The lack of alteration in the thiol levels 4
wks post exposure (when incubated for 16 hrs in thiol free media) is not surprising. The cultured
AM from the Brown Norway rats had only slightly higher levels of CYSH than GSH (on a molar
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basis), while CYSH from cultured pulmonary associated lymph node lymphocytes was
approximately 7 times that of GSH. Both cell types displayed a strong capacity for the uptake
and reduction of the disulfide, cystine. The OVA exposure to sensitized rats had a marked effect
decreasing thiol levels in AM and lymph node lymphocytes, and their ability to take up and
reduce cystine. Interestingly, AM, but not lymph node lymphocytes from DEP and CB exposed
rats had significantly greater levels of cystine uptake and reduction over saline controls. DEP and
CB exposure also significantly restored the capacity of AM from OVA sensitized/challenged rats
to take up and reduce cystine (Fig 26A).
The interplay between particle and OVA exposure on lymphocyte GSH levels from the
current study is not clear, probably due to the strong OVA effect. Lymphocytes from animals
exposed to both DEP and OVA were not able to maintain their intracellular GSH level (vs.
OVA-only exposure) when incubated for 16 hrs in thiol-free media (Fig. 27B). This enhanced
loss of GSH was not seen when the lymphocytes were cultured with cystine (Fig. 29B). These
results suggest that depletion of intracellular GSH and CYSH may have a role in, or be a
consequence of allergic pulmonary responses, or as a result of increased reactivity of the
lymphocyte (i.e. in hypertonic media) as discussed earlier. This is consistent with the results of
our previous work in which in vitro DEP exposure of pulmonary associated lymph node cells
resulted in a depletion of intracellular GSH, even at increased CYSH concentrations and
glutathione reductase activity (Al-Humadi et al., 2002-1). The role of particulates and antigens in
the (altered) thiol regulation in these immunologically relevant cells is not known. Thiols have
been suggested to be important in signal transduction pathways involving NFκB activation
(Droge et al., 1994; Haddad et al., 2000), which is associated with a number of cytokine genes
including interferon, TNF-α, IL-4, IL-6, and transforming growth factor-α (Shukla et al., 2000).
Modulation of thiol regulation by particulates may thus affect allergic outcomes.
In summary, the present study shows that DEP- and CB-exposed rats exhibit an
aggravated allergic response to OVA exposure with markedly enhanced pulmonary
inflammation, IL-4 mRNA levels in lung tissue, and serum OVA-specific IgG and IgE levels
similar to the effect reported in mice. The results also confirm the finding of other reports that
the carbonaceous particles alone induce adjuvant effect on allergic asthma, however the organic
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component of DEP may also contribute in some aspects aggravating the disease. The role of
thiols in the adjuvant effect of DEP remains a complicated issue. Both particulate (DEP and CB)
and antigen challenge alter thiol parameters. The extent and type of alteration are tissue
dependent. AM as a model of APCs and LNC were studied. AM from DEP exposed OVA
sensitized rats were less affected with respect to thiol depletion, which may have a role in its IgE
adjuvant effect (or inhibition of tolerance).
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TABLES
Table 1. Percent CD4+ and CD8+ Cells in Selected Lymph Nodes
Treatment

Lymph Nodes
Tracheal & Thymic

Axiliary

Unstained

0.03

1.82

CD4+

26.54

38.21

CD8+

10.73

18.21
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Table 2. Cysteine and Glutathione Levels in the Pulmonary Associated and Axiliary Lymph
Nodes and Alveolar Macrophages of Sprague Dawly Rats.
Tissue
Axiliary Lymph Nodes
Tracheal and Thymic Lymph
Nodes
Alveolar Macrophages

Cysteine ng/Million Cell
10.53
12.41

GSH ng/Million Cell
53.28
83.86

305.16

170.469
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Table 3. Comparison of Lymph Node and BAL Cells at 72 hours after either IT or Inhaled DEP
exposure.
IT-DEP 1

Inhaled-DEP 1

GSH-LN

138.22 ± 18.4 ^

128.98 ± 17.5

Cysteine-BAL Cells

148.45 ± 16.3 ^

128.0 ± 19.0

GSH-BAL Cells

105.90 ± 6.3

98.7 ± 4.5

PMN-BAL Cells

383.81 ± 21.5 * ^

108.28 ± 10.3

LDH-BAL

324.04 ± 15.2 * ^

87.9 ± 13.6

Total Protein

224.10 ± 15.3 * ^

95.6 ± 4.4

Albumin

187.10 ± 7.3 * ^

88.9 ± 11.1

+ LPS2,3

- LPS1,2

+ LPS2,3

- LPS1

TNF-α

56.3* ^ ± 10.0

80 ± 8.8 ^

82.3* ± 9.7

58.8* ± 9.9

IL-1

76.5 * ^ ± 14.5

94.8 ± 5.9

117.1 ± 13.6

82.2 ± 10.7

1

% Control (Control = IT-Saline or Air Sham Nose-Only Exposure)

2

Ex Vivo addition of LPS (0.1ug/ml) to AM

3

% Control (Control = IT-Saline or Air Sham Nose-Only Exposure + ex vivo LPS)

*

Different from Control, t-test, P # 0.05

^

IT Different from Inhalation, Chi-square, P # 0.05
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Table 4. Comparison of Brown Norway (BN) and Sprague-Dawley (SD) Rat Responses to DEP
exposure.
Exposure Time (hours)
4
Strain
Analyt

GSH-LNC
CYSH-AM
GSH-AM
PMN
LDH
Total
Protein

24

72

BN*

SD*

BN*

SD*

BN*

SD*

109.1
221.7
147.9
206.4

96.3
125.0
79.5
148.5

260
143.3
121.3
526.4
199.1
164.7

130.2
1276.0
330.1
671.9
256.2
163.1

159.0
175.9
115.1
477.3
336.7
231.3

95.4
1551.7
392.8
696.3
265.8
220.0

* % of Saline Control
(Note: BN = Brown Norway Rats, SD = Sprague-Dawley Rats)
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Table 5. Experimental Design
Route of Exposure
IT
Day

Inhalation**

0

1, 8, 15, 29

30

Saline

Saline

Sacrifice

CB/Saline

CB*

Saline

Sacrifice

DEP/Saline

DEP*

Saline

Sacrifice

Saline/OVA

Saline

OVA

Sacrifice

CB/OVA

CB

OVA

Sacrifice

DEP/OVA

DEP

OVA

Sacrifice

group
Saline/Saline

* 5 mg/kg body weight
** 90 ± 18 mg OVA/m3 air or saline vehicle
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FIGURES
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Fig 1. Fluorescent microscopic images of MBB stained rat alveolar macrophage
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Fig 4. The OVA dose response effect on inflammatory responses in Brown Norway rats as
indicated by elevations of granulocytes (A), lactate dehydrogenase activity (B), total protein
content and albumin (C) in the bronchoalveolar lavage fluid (BAL).
n = 5/group. Each point represents average ± SEM.
* Significantly different from saline control at P < 0.05, t-test.
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n = 5/group. Each point represents average ± SEM.
* Significantly different from saline control at P < 0.05, t-test.
+ Significantly different from 68 mg/m3 at P < 0.05, t-test.
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n = 5/group. Each point represents average ± SEM.
* Significantly different from saline control at P < 0.05, ANOVA.
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n = 5/group. Each point represents average ± SEM.
* Significantly different from saline control at P < 0.05, ANOVA.
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Fig 10. OVA dose dependent effect on the levels of intra- and extra- cellular CYSH (A) and
GSH (B) in the alveolar macrophage after 16 hour’s ex vivo incubation in thiol free medium.
n = 5/group. Each point represents average ± SEM.
* Significantly different from saline control at P < 0.05, ANOVA.
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Fig 12. Nose only inhalation system for diesel exhaust particles
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Fig 13. Electron micrographs of CB and DEP
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Fig 16. The effect of IT-DEP on the levels of TNF-alpha and IL-1 in AM conditioned medium
with and without ex vivo LPS stimulation
* Significantly different from saline control (-LPS) at P < 0.05, t-test
# Significantly different from saline control (+LPS) at P < 0.05, t-test
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treatment.
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65

A

**
*

30

20

*

10

0

20

15

*

*

10

5

----------------------------------------

----------------------------------------

----------------------------------------

W

ith

C
ys
tin
e

ys
tin
e
C

ith
ou
t

C
ys
tin
e
W

W

W

ith

C
ys
tin
e
ith
ou
t

C
ys
tin
e

W
ith

ys
tin
e

ith
ou
t

C

ys
tin
e
C
W

W

ith

C
ys
tin
e

0

ith
ou
t
W

B

25

GSH, ng/Million LNC

Cysteine, ng/Million LNC

40

----------------------------------------

Saline-Exposed DEP-Exposed

Saline-Exposed DEP-Exposed
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Fig 26. Measurement of intracellular cysteine (A) and GSH (B) levels in AM harvested from rats
exposed to saline, CB, DEP, OVA, or both particles (CB or DEP) and OVA, after ex vivo
incubation for 16 hr.
n = 5/group. Each point represents average ± SEM.
* Significantly different from saline-saline control at P < 0.05, ANOVA.
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Fig 27. Measurement of intracellular cysteine (A) and GSH (B) levels in para-thymic and
tracheal lymph node lymphocytes harvested from rats exposed to saline, CB, DEP, OVA, or both
particles (CB or DEP) and OVA, after isolation with ficoll-hypaque and ex vivo incubation for 16
hr.
n = 5/group. Each point represents average ± SEM.
* Significantly different from saline-saline control at P < 0.05, ANOVA.
+ Significantly different from saline-OVA at P < 0.05, ANOVA.
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n = 5/group. Each point represents average ± SEM.

* Significantly different from saline-saline w/cystine control at P < 0.05, ANOVA.
+ Significantly different from saline-OVA w/cystine control at P < 0.05, ANOVA.
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Fig 29. Measurement of intracellular cysteine (A) and GSH (B) levels in para-thymic and
tracheal lymph node lymphocytes harvested from rats exposed to saline, CB, DEP, OVA, or both
particles (CB or DEP) and OVA, after isolation with ficoll-hypaque and ex vivo incubation with
24 µg/ml cystine for 16 hr.
n = 5/group. Each point represents average ± SEM.
* Significantly different from saline-saline w/cystine control at P < 0.05, ANOVA.
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OVERALL CONCLUSION
In this study the effect of OVA sensitization and challenge on the levels of CYSH and
GSH in BAL, AM, and LNC were shown. OVA challenge may have caused an oxidative stress,
increasing the demand on antioxidants systems. A concomitant change in the blood serum
immunoglobulin levels was also reported. The relationship between thiol and immunological
changes is not conclusive from these studies. DEP, indeed, affects the levels of thiols in both AM
and LNC and also affected the thiol regulation behavior of these two cell populations. This, in
part, may be related to the effect of DEP on the GSH-reductase activity, which was increased in
both cell types.
Cells, like alveolar macrophages, control their GSH levels by at least three different
enzymes. These are involved in controlling the redox status and the synthesis of GSH. These
enzymes are: (-glutamylcysteine synthetase, a rate limiting enzyme for GSH synthesis; (glutamyl transpeptidase which breaks down the extracellular GSH and makes cysteine available
for the intracellular usage for GSH synthesis; and GSH-reductase, which reduces disulfide
bonds. Affecting the activity of any of these enzymes might perturb the levels of GSH available
for the cells. A xenobiotic may alter thiol regulation by directly or indirectly interacting with one
or more of these enzymes. Alteration of cellular thiol transport is another potential target.
OVA challenge and DEP exposures caused significant changes in thiol levels in both AM
and LNC with a concomitant increase in the immunoglobuline levels. Allergic challenge caused
major changes in cellular thiol levels, which were partially alleviated by pre exposure to DEP. In
addition, the combined exposure increased the levels of IL-4 mRNA expression in lung tissue.
Both OVA and DEP separately affected the level of thiols in both AM and LNC. DEP increased
OVA specific IgE (a Th2 type response) level in the serum of OVA sensitized rats. The results of
these studies demonstrate that both allergic sensitization/challenge and particulate effect alter
thiols in target tissues. The alterations by DEP seem to be particulate mediated as similar affects
were caused by CB. While direct ties between DEP effects on thiol regulation and immune
alterations can not be determined from these studies, it is interesting to note the seemingly
protective affect of DEP on AM thiols following allergic challenge. It could be speculated that
this may help preserve its antigen presentation ability and prevent the IgE tolerance noted.
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coupled to three different detectors (UV, Fluorometer and Electrochemical). I have acquired a
good working knowledge of several additional instruments including the gamma and beta
counters, Coulter counter with channelizer, and lyophilizer. These analyses were performed to
identify and quantitate biomarkers of disease and exposure in animal models and from human
occupational disease studies.
Grain Processing Industry, Agriculture Engineer (06/ 1985- 11/ 1989): Duties
included; setting imported wheat and flour specifications, oversaw the quality of flour and wheat
in private sector factories. I have also used the Amylograph, Pharinograph, and Extensograph
Instruments to evaluate the quality of the produced flour. Furthermore, I have supervised more
than 50 laborers. Other responsibilities included operating and adjusting the flour production
equipment. Setting the flour and the ingredients (improver, salt, sugar, yeast, and water)
specifications. I have operated and adjusted the bread production equipment.
Computer Experience:
Word Perfect 5.1, 6.0, 6.1 and 9, Microsoft World, Microsoft Excel, Microsoft Power Point,
Corel Draw9, Sigma Plot, Sigma Stat, Instat, figP, and Draw Perfect.
Awards:
1- Outstanding Effort in promoting the goals of NIOSH 1998-1999.
2- Performance award for the year 1999.
3- Performance award for the year 2000.
4- Performance award for the year 2001.
ABSTRACTS
* NH Al-Humadi, PD Seigel, DM Lewis, MW Barger, JYC Ma, DN Weissman, and JKH Ma.
Thiol and Immune Exposure Dependent Response to Ovalbumin in Sensitized Rats. The
Toxicologist, March 17-21, 2002.
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* NH Al-Humadi, PD Seigel, DM Lewis, MW Barger, JYC Ma, DN Weissman, and JKH Ma.
Adjuvant Effect of Diesel Exhaust Particles (DEP) and Carbon Black (CB) on Pulmonary
Allergic Sensitization. Submitted to the 3rd International Conference on Oxygen/Nitrogen
Radicals: Cell injury and Disease Conference. Morgantown, WV, June 2002.
* NH Al-Humadi, PD Seigel, DM Lewis, MW Barger, JYC Ma, DN Weissman, and JKH Ma.
Role of Thiols in Pulmonary Immune Response to Allergic Sensitization: Adjuvant Effect of
Diesel Exhaust Particulate (DEP). AAPS Pharm Sci., Abstract No. T3449, pp 196, 2001.
* NH Al-Humadi, Seigel PD, Lewis DM, Barger M, Ma JYC, Weissman DN, and Ma JKH.
Effect of Exposure to Diesel Exhaust Particles (DEP) on Pulmonary Allergic Sensitization.
Presented at the International Congress of Society of Toxicology. Australia, Brisbane, July 8-12,
2001.
* NH Al-Humadi, PD Siegel, DM Lewis, JYC Ma, and JKH Ma. Diesel Exhaust Particulate
(DEP) Affected Thiol Levels in Both Alveolar Macrophages (AM) and Lymph Node Cells
(LNC). The Toxicologist, 60 (1): 167, 2001.
* C Kommineni, A Shvedova and NH Al-Humadi. Used Semi-synthetic Metal Working Fluid
(UMWF): Dermal and Systemic Effect in B6C3F1 Mice. The Toxicologist, 60 (1): 59, 2001.
* NH Al-Humadi, P.D. Siegel, JYC Ma, WJ Jones, MW Barger, D Lewis and JKH Ma.
Comparison of Pulmonary Response to Inhaled and Inratracheally Instilled Diesel Exhaust
Particulate. The Toxicologist, 54 (1): 14, 2000.
* C Kommineni, Elena Kisin, NH Al-Humadi, V Castranova and AA Shvedova,. Elevated
Oxidative Stress in Skin of B6C3F1 Mice Affects Dermal Exposure to Machine Working Fluid.
The Toxicologist, 54 (1): 141, 2000.
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* NH Al-Humadi, P.D. Siegel, JYC Ma, JC Mull, LF Butterworth and JKH Ma. Fluorometeric
Determination of Thiol Concentrations in Cells from Pulmonary Associated Lymph Nodes and
Alveolar Macrophages. AAPS Pharm Sci. 1: 2748, 1999.
* C Kommineni, Elena Kisin, NH Al-Humadi, V Castranova and AA Shvedova,. Elevated
Oxidative Stress in Skin of B6C3F1 Mice Affects Dermal Exposure to Machine Working Fluid.
Presented in the 14th Annual Conference of the Developmental Immunotoxicology: Research and
Risk Issues, Morgantown, WV, September 8-10, 1999.
* NH Al-Humadi, C Kommineni, AA Shvedova, L Battelli, and V Castranova. Adverse
Responses to Semi-synthetic Metal Working fluids in B6C3F1 mice. The Toxicologist, 48 (1-S):
76, 2000.
* M. Iqbal, PB Kenney, H. Klandorf, and Nabil H. Al-Humadi. Effect of Age, Diet Restriction
and Aminoguanidine on Mechanical Properties and Pentosidine in Tendon of Broiler Breeder
Hens. Presented in the FASEB Experimental Biology Meeting, April 17-21, 1999, Washington,
DC.
* M. Iqbal, L.L. Probert, PB Kenney, H. Klandorf, and Nabil H. Al-Humadi. Effect of Age,
Diet Restriction and Aminoguanidine on Skin Pentosidine and Meat Tenderness in Broiler
Breeder Hens. The Southern Poultry Science Society, Volume 77, Supplement I, P. 103 Abstract
# 392. Presented in the Poultry Science Association 19th Annual Meeting ,Pennsylvania State
University, PA, August 2-5, 1998.
* M. Iqbal, L.L. Probert, H. Klandorf, K Van Dyke, and Nabil H. Al-Humadi. Effect of Age,
Diet Restriction and Aminoguanidine on Pentosidine in the Skin of Broiler Breeder Hens. The
FASB Journal, Volume 12, Number 5, Part II, P. A879, Abstract # 5088. Presented in FASB
Annual Meeting , San Francisco, CA, April 18-22, 1998.
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* Nabil H. Al-Humadi, C. Kommineni , L. Batteli, P. Willard, D. Schwegler-Berry, and V.
Castranova. MWF Effects on the B6C3F1 Mice Skin. Metal Working Fluids Symposium II, PP
398-401, 1997 (Detroit, Michigan).
* Nabil.H. Al-Humadi, P.D. Siegel. Fluorometric and Electrochemical FMLP HPLC Analysis.
Eighth Annual Meeting of the Allegheny-Erie Regional Chapter of the Society of Toxicology,
May 31, 1996.
* Nabil H. AL-Humadi, M.Z.A. Nomani, Amy B. Schrecengost, and Wendy L. Stuhldreher.
Nutritive value and acceptability of wheat flour bread supplemented with chickpea and triticale
flour. The FASB Journal, Volume 7, Number 4, Part II, P. A582, Abstract # 3372, February 23,
1993.
* M.Z.A. Nomani, Amy B. Schrecengost, Nabil H. AL-Humadi, and Wendy L. Stuhlderher.
Wheat flour cookies supplemented with chickpea and triticale flours. The FASB Journal,
Volume 7, Number 4, Part II, P. A582, Abstract # 3373, February 23, 1993.
* P.D. Siegel, N.H. AL-Humadi, P.R. Clark, and E.A. Ronk. Biological considerations in the
use of breath alkanes (and alkenes) as markers of lipid peroxidation. Oxygen Radicals and Lung
Injury Conference, August 30 - September 2, Morgantown, West Virginia, 1993.
* N. AL-Humadi, A. Hubbs, E. Ronk, J. Xiang, P. Turner,and P.D.Siegel. The Effect of NO2 in
Acute Lower Lung Irritation in Pulmonary Allergic Sensitization. (Presented in the local AESOT
meeting, June, 1994).
* P.D. Siegel, N. Al-Humadi, A. Hubbs, E. Ronk, J. Xiang, and P. Turner. Adjuvant effect of
acute lower lung irritation in pulmonary allergic sensitization. The International Toxicologist, 71,
P.3, 1995.
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* Nabil H. AL-Humadi, and S. Toma. To Investigate the use of Dry Milk in the Manufacturing
of Dairy Products, Journal of Agricultural Sciences, Baghdad, Iraq, 1985.
PUBLICATIONS
* NH Al-Humadi, PD Seigel, DM Lewis, MW Barger, JYC Ma, DN Weissman, and JKH Ma
(2002). The Effect of Diesel Exhaust Particles (DEP) and Carbon Black (CB) on Thiol Changes
in Pulmonary Ovalbumin Allergic Sensitized Brown Norway Rats. Experimental Lung Research,
28: 333-349.
* NH Al-Humadi, PD Siegel, DM Lewis, Mark W. Barger, JYC Ma, and JKH Ma (2002).
Alteration of Intracellular Cysteine and Glutathione Levels in Alveolar Macrophages and
Lymphocytes by Diesel Exhaust Particle Exposure. Environmental Health Perspective, 110: 349353.
* Nabil H. Al-Humadi, Shvedova A., Battelli L., Diotte N., Castranova V., and Kommineni C
(2000). Dermal and Systemic Toxicity after Application of Semi-synthetic Metal Working Fluids
in B6C3F1 Mice. J. Toxic. Envir. Health, part A, 61: 579-589.
* Nabil H. Al-Humadi, C. Kommineni , L. Batteli, P. Willard, D. Schwegler-Berry, and V.
Castranova (2000). MWF Effects on the B6C3F1 Mice Skin. Journal of Toxicology and
Industrial Health, 16: 203-210.
* Muhammad Iqbal, P.B. Kenney, N.H. Al-Humadi, and H. Klandorf (2000). Relationship
between Mechanical Properties and Pentosidine in Tendon: Effect of Age, Diet Restriction and
Aminoquanidine in Broiler Breeder Hens. J. Poultry Sci., 79: 1338-1344.
* Paul D. Siegel, Nabil H. Al-Humadi, L.L. Millecchia, V.A. Robinson, A.F. Hubbs, E.R.
Nelson, and J.S. Fedan (2000). Ovalbumin Aeroallergen Exposure-Response in Brown Norway
Rats. Inhalation Toxicology, 12: 245-261.
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* M. Iqbal, L.L. Probert, N.H. Al-Humadi, and H. Klandorf (1999). Protein Glycosylation and
Advanced Glycosylated End product (AGE) Accumulation: An Avian Solution? Journal of
Gerontology: Biological Science, 54A: B171-B176.
* Nabil.H. Al-Humadi, P.D. Siegel (1997). Fluorometric and Electrochemical FMLP HPLC
Analysis. Proceedings-Beltwide Cotton Conferences.(Eds Paul Dugger, and Debbie Richter).
Volume 1 PP 202-205.
* Paul D. Siegel, Nabil H. Al-Humadi, Elizabeth R. Nelson, Daniel M. Lewis, and Ann F.
Hubbs (1997). Adjuvant Effect of Respiratory Irritation on Pulmonary Allergic Sensitization:
Time and Site Dependency. Toxicology and Applied Pharmacology 144, 356-362.
* P.D. Siegel, S. Short, W.G. Jones, N.C. Leppla, D.M. Lewis, B. Ducatman, E.A. Ronk, T.
Bledsoe, B. Husberg, E. Jennison, E. Janotkova, J.C. Mull, T.A. Shahan, N.H. Al-Humadi, D.
Freeland, J. Odencrantz, E.L. Petsonk (1995). Nasal Lavage for Exposure and Health
Assessment. People and Work. Research Report 3, pp.81-87.
* D.G. Frazer, V.A. Robinson, P.D. Siegel, N. Al-Humadi, A.A. Afshari, W.T. Goldsmith, S.
Olenchock, M.P. Whitmer and V. Castranova (1996). Response of An Animal Model to
Mixtures of Endotoxin and N-Formyl-Methionyl-Leucyl-Phenylalanine (FMLP) Aerosols. Proc.
Of the twentieth Cotton & Other Organic Dusts Res. Conf. (eds. PJ Wakelyn, RR Jacobs and R.
Rylander). PP 360-363.

SEMINARS ATTENDED
* 08/ 07/ 97- 08/ 10/ 97, 3-Day Millennium System with 996 PDA course (HPLC, by Waters),
Cincinnati, Ohio.
* 10/ 28/ 89- 11/ 2/ 89, Conference of the America Association of Cereal Chemists (AACC)
meeting in Washington, D.C.
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* 02/ 23/ 89- 02/ 26/ 89, Seminar in grain storage and handling, held in Baghdad, Iraq by the
U.S. Wheat Associates.
PROFESSIONAL AFFILIATIONS
* American Association of Pharmaceutical Scientist.
* Allegheny-Erie Regional Chapter of the Society of Toxicology.
COMMUNITY SERVICE
* Registered referee with the United States Soccer Federation (Grade 8) and with the National
Federation Interscholastic Officials Association. Officiating recreational, local tournaments and
high school games.
REFERENCES
* Dr. Paul Siegel, Research Chemist; NIOSH/ALOSH, Immunology Section, 1095 Willowdale
Road, Morgantown, WV 26505. Phone #: (304) 285-5855.
* Dr. Daniel Lewis, Branch Chief; NIOSH/ALOSH, Immunology Section, 1095 Willowdale
Road, Morgantown, WV 26505. Phone #: (304) 285-5720.
* Dr. Joseph Ma, Professor; West Virginia University, School of Pharmacy, Basic
Pharmaceutical Sciences, Morgantown, WV 26506-6124. Phone #: (304) 293-1449.
* Dr. Vincent Castranova, Branch Chief; NIOSH/ALOSH, Pathology & Physiology Branch,
1095 Willowdale Road, Morgantown, WV 26505. Phone #: (304) 285-6032.
LANGUAGE SKILLS
* English: Near Native fluency in speaking, reading and writing.
* Arabic: Native fluency in speaking, reading and writing.
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